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Background: Spaceflight associated neuro-ocular syndrome (SANS) is a condition in which 
worsening vision occurs while in microgravity. It has been hypothesized that SANS is caused by 
an increase in intracranial pressure (ICP) due to the cephalad fluid shift that occurs in microgravity, 
however, due to the invasive nature of ICP measurements, ICP cannot safely be measured in 
microgravity. Non-invasive estimates of ICP (nICP) act as surrogates for ICP, but few methods of 
nICP are validated and all currently involve an operator and contact with the skin. Indicators of 
cerebral venous congestion, such as internal jugular vein cross-sectional area (IJV CSA) and 
central venous pressure (CVP), have not been utilized to reflect changes in nICP to date, despite 
the association between IJV CSA, CVP and ICP. Coded Hemodynamic Imaging (CHI) is a novel, 
non-contact camera device which uses infrared light to “see” blood volume in the superficial 
vasculature and to track changes in the jugular venous pulse. By leveraging CHI’s ability to detect 
cardiovascular biomarkers of IJV hemodynamics, it was hypothesized that changes in jugular 
venous absorption (JVA) as measured by CHI would be associated with changes in nICP during 
head-down tilt (HDT), a common surrogate for microgravity.   
Objective: (1) To determine the ability of JVA, determined by CHI, to track changes in IJV CSA, 
CVP, and nICP during a severe cephalad fluid shift induced by 12° HDT and 30° HDT. (2) To 
determine the effect of a severe cephalad fluid shift on cerebral venous outflow (IJV CSA and IJV 
blood flow), and how those changes are associated with nICP.  
Methods: Eleven healthy young adults (5 female, 26±6 years, 166±10 cm, 64±11 kg) underwent 
ophthalmic ultrasound, IJV ultrasound and CHI imaging after 5-minutes in supine (baseline), and 
every 5-minutes up to 20-minutes in 12° HDT, 30° HDT and again in supine (recovery). 
Transcranial Doppler (TCD) continuously measured the velocity of the middle cerebral artery and 
5 participants had CVP continuously monitored by a catheter in a right antecubital vein.  Repeated 
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measures correlation as well as individual regression were used to test the association between 
JVA and nICP as measured by nICP-TCD and optic nerve sheath diameter (ONSD). Linear mixed 
models were used to determine how IJV CSA, IJV blood flow, nICP-TCD and ONSD changed 
with HDT and over time. Repeated measures correlation was used to test the associations between 
IJV CSA, IJV blood flow, nICP-TCD, and ONSD.  
Results: JVA and IJV CSA had a moderate positive association (rrm=0.51, p<0.001; rmean=0.57, 
rmedian=0.78), as did JVA and CVP (rrm=0.48, p<0.001; rmean=0.45, rmedian=0.67, n=4). JVA and 
nICP-TCD had a weak positive association (rrm=0.28, p=0.003; rmean=0.24, rmedian=0.31) as did 
JVA and ONSD (rrm=0.17, p=0.078; rmean=0.09, rmedian=0.17). HDT had a significant main effect 
on IJV CSA (p<0.001), nICP-TCD (p<0.001), and ONSD (p<0.05) but not on IJV blood flow 
(p=0.70). Time had no significant main effect on any variable. IJV CSA and nICP-TCD 
significantly increased at 30° HDT compared to baseline (p<0.001) but did not result in a 
significant change in IJV blood flow or ONSD.  
Conclusions: JVA, determined by CHI, was moderately associated with both IJV CSA and CVP, 
suggesting that CHI-derived-JVA can track changes in cardiovascular biomarkers during a severe 
cephalad shift. However, JVA had a weak association with nICP, suggesting that CHI-derived-
JVA does not provide the same information as nICP. Due to the limitations of nICP, future studies 
should determine the association between JVA and invasive ICP to better determine the ability of 
CHI to be an nICP surrogate. Lastly, while IJV CSA and nICP-TCD significantly increased with 
30° HDT, IJV blood flow remained the same, suggesting that the relationship between IJV 
hemodynamics, cerebral venous congestion and nICP during a cephalad fluid shift is more 
complex than what these measures can capture alone. Future work should focus on identifying 




Firstly, I would like to thank my supervisor Dr. Richard Hughson for giving me the 
opportunity to complete this Masters thesis and making me part of the FAST research team, which 
has allowed me to learn about the research process in-depth. I would also like to thank him for 
supporting my love for space physiology and for allowing for me to immerse myself in that world 
as much as possible, showing me that this was something I could truly do for the rest of my life. 
To Dr. Robert Thirsk, Dr. Wayne Giles, Dr. John V. Tyberg, and Dr. Doug Hamilton, thank 
you for opening the world of space cardiovascular physiology to me while I was a student at 
University of Calgary, and introducing Dr. Hughson and me, it was truly life changing. 
I would like to thank my committee, Dr. Jason Au and Dr. Elizabeth Irving for all of the 
insight and support they have provided throughout my project.  
Thank you to Dr. Andrew Robertson and Dr. Robert Amelard for including me so heavily 
in all of the FAST projects. Your support throughout my degree has been immense, and without 
your guidance on everything out from poster design to stats in R, I’m not sure I could have ever 
finished, and I am eternally grateful.  
I would also like to thank the rest of the FAST team, Essi Saarikoski, Daniel Lwis, Hannah 
Heigold and Yara Mohair for working tirelessly on data collection and analysis. 
To Eric Hedge, I thank you for being a brilliant lab mate and an amazing friend. It has been 
an honour to complete this entire Masters adventure with you by my side.  
A special thanks to Dr. Danielle Greaves and Dr. Philippe Arbeille for teaching me how to 
perform and analyze ophthalmic ultrasound, and for answering all of my questions regarding the 
Sonoscanner and ultrasound technique. 
Thank you to my family for supporting me throughout all of my education, especially in 
recent years when my continuing education has meant living 3200km away from home.  
Lastly, I would like to thank my boyfriend 2LT Elijah McAlpine. Thank you for everything 
you do for me, you have been both my biggest emotional support and my biggest cheerleader. You 
believe in me more than I believe in myself. I love you, and I can’t wait to see you soon.  
 
 
Per aspera ad astra 
vi 
 
Table of Contents 
Author’s Declaration ....................................................................................................................... ii 
Abstract .......................................................................................................................................... iii 
Acknowledgements ......................................................................................................................... v  
List of Figures .............................................................................................................................. viii 
List of Tables ................................................................................................................................. ix 
List of Equations ............................................................................................................................. x 
List of Acronyms ........................................................................................................................... xi 
1.0 BACKGROUND/LITERATURE REVIEW ............................................................................ 1 
1.1 Preamble: Monitoring ICP to assess the risk of SANS in long-duration spaceflight ........... 1 
1.2 Intracranial Pressure .............................................................................................................. 3 
1.3 Non-Invasive Measures of Intracranial Pressure .................................................................. 7 
1.4 Jugular Vein Cross-sectional Area, Central Venous Pressure and Intracranial Pressure.... 14 
1.5 Coded Hemodynamic Imaging............................................................................................ 19 
1.6 Head-Down Tilt as a Microgravity Analog......................................................................... 24 
2.0 RATIONALE .......................................................................................................................... 31 
3.0 RESEARCH QUESTIONS, OBJECTIVES AND HYPOTHESES: ..................................... 31 
Main Research Questions .......................................................................................................... 31 
Hypothesis #1 ............................................................................................................................ 32 
Objective #2 .............................................................................................................................. 32 
Hypothesis #2 ............................................................................................................................ 32 
4.0 GENERAL METHODOLOGY: ............................................................................................. 32 
4.1 Ethics and Funding .............................................................................................................. 32 
4.2 Recruitment ......................................................................................................................... 32 
4.3 Overview and Data Collection ............................................................................................ 33 
4.4 Data Analysis ...................................................................................................................... 38 
4.5 Statistical Analysis .............................................................................................................. 41 
5.0 RESULTS ............................................................................................................................... 42 
5.1 Participant Characteristics ................................................................................................... 42 
5.2 Associations between JVA, IJV CSA and CVP .................................................................. 45 
5.3 Associations between JVA, nICP-TCD and ONSD............................................................ 48 
5.4 Changes in IJV blood flow, IJV CSA, ONSD, and nICP-TCD with HDT ......................... 53 
5.5 Associations between IJV blood flow, ONSD, and nICP-TCD .......................................... 58 
vii 
 
5.6 Associations between IJV CSA, ONSD, and nICP-TCD ................................................... 61 
6.0 DISCUSSION: ........................................................................................................................ 62 
6.1 Associations between JVA, IJV CSA and CVP .................................................................. 62 
6.2 Limited association between JVA, nICP-TCD and ONSD................................................. 64 
6.3 Severe HDT results in changes in IJV CSA and nICP-TCD but not IJV blood flow or 
ONSD ........................................................................................................................................ 67 
6.4 No relationship between IJV blood flow, ONSD, and nICP-TCD ..................................... 75 
6.5 Limited associations between IJV CSA, ONSD, and nICP-TCD ....................................... 76 
7.0 LIMITATIONS: ...................................................................................................................... 76 
8.0 SIGNIFICANCE AND FUTURE DIRECTIONS: ................................................................. 78 
9.0 CONCLUSION: ...................................................................................................................... 80 




List of Figures 
 
Figure 1: The risk matrix for Spaceflight Neuro-Ocular Syndrome (SANS) ................................. 1 
Figure 2: Placement for different methods of invasive ICP monitoring ......................................... 4 
Figure 3: Intracranial pressure during parabolic flight ................................................................... 7 
Figure 4: The anatomy of the Optic Nerve Sheath ......................................................................... 9 
Figure 5: The process of obtaining optic nerve sheath diameter using ultrasound. ...................... 11 
Figure 6: Location of ONSD, nICP-TCD, IJV CSA and CVP measurements compared ICP ..... 14 
Figure 7: Venous anatomy of the cerebrum and neck .................................................................. 15 
Figure 8: The jugular venous pulse waveform ............................................................................. 16 
Figure 9: Coded-Hemodynamic Imaging (CHI) system ............................................................... 19 
Figure 10: An overview of how CHI derives information ............................................................ 20 
Figure 11: Individual data showing the JVP waveform (black line) evaluated by CHI ............... 21 
Figure 12:  JVP waveform detected by CHI compared to the classical JVP waveform ............... 22 
Figure 13: Pilot data directly comparing CHI IJV pulsatility to CVP. ......................................... 22 
Figure 14: Internal jugular vein (IJV) compared to CVP and CHI traces. ................................... 23 
Figure 15: Study diagram.............................................................................................................. 35 
Figure 16: Image set up for CHI. .................................................................................................. 36 
Figure 17: Analysis of IJV CSA in ImageJ .................................................................................. 39 
Figure 18: Caliper placement for measuring ONSD ..................................................................... 40 
Figure 19: Repeated measured correlation between JVA and IJV CSA ...................................... 45 
Figure 20: Individual correlations between JVA and IJV CSA .................................................... 46 
Figure 21: Repeated measured correlation between JVA and CVP ............................................. 47 
Figure 22: Individual correlations between JVA and CVP .......................................................... 48 
Figure 23: Repeated measured correlation between JVA and nICP-TCD ................................... 49 
Figure 24: Repeated measured correlation between JVA and ONSD .......................................... 50 
Figure 25: Individual correlations between JVA and nICP-TCD ................................................. 51 
Figure 26: Individual correlations between JVA and ONSD ....................................................... 53 
Figure 27: IJV blood flow across all conditions of HDT.............................................................. 54 
Figure 28: IJV CSA across all conditions of HDT ....................................................................... 56 
Figure 29: ONSD across all conditions of HDT ........................................................................... 57 
Figure 30: nICP-TCD across all conditions of HDT .................................................................... 58 
Figure 31: Repeated measures correlation between IJV blood flow and ONSD .......................... 59 
Figure 32: Repeated measures correlation between IJV blood flow and nICP-TCD. .................. 60 
Figure 33: Repeated measures correlation between IJV CSA and ONSD ................................... 61 
Figure 34: Repeated measures correlation between IJV CSA and nICP-TCD ............................. 62 
ix 
 
List of Tables  
 
Table 1: Summary of clinical results comparing ONSD to ICP. .................................................. 13 
Table 2: Summary of findings regarding HDT and ICP. .............................................................. 26 
Table 3: Summary of findings of ONSD in Trendelenburg position >25° ................................... 27 
Table 4: Summary of findings of IJV CSA in HDT. .................................................................... 30 
Table 5: Inclusion and exclusion criteria for “The association of Coded Hemodynamic Imaging 
with markers of blood vessel and eye health during short-duration head down tilt” study. ......... 33 
Table 6: Participant demographic information. Physiological information was taken during 
baseline. Where SBP=systolic blood pressure, DBP=diastolic blood pressure, HR=heart rate, 
BMI=body mass index. ................................................................................................................. 43 
Table 7: Mean±standard deviation for physiological variables during all HDT conditions. n=11 
unless otherwise indicted. ............................................................................................................. 44 
Table 8: Individual intercepts, slopes, r2, and r values for each participant between JVA and 
nICP-TCD. .................................................................................................................................... 51 
Table 9: Individual intercepts, slopes, r2, and r values for each participant between JVA and 
ONSD. ........................................................................................................................................... 52 
Table 10: Visual grading of IJV blood flow for all participants across three HDT conditions. This 
visual identification scale was created by Marshall-Goebel et al., (2019). Grade 1 indicates 
continuous forward flow. Grade 2 indicated pulsatile flow that returns to 0. Grade 3 indicates 
equal amounts of forward and reverse flow. ................................................................................. 55 
Table 11: Individual ONSD values across all HDT conditions. Highlighted participants indicate 
those that received drops of Proparacaine Hydrochloride in both eyes prior to supine 
measurements. ............................................................................................................................... 73 
x 
 
List of Equations 
 
Equation 1: ICP as defined by Monro-Kellie ................................................................................. 3 
Equation 2: The Heldt equation for estimating ICP (nICP) from continuous ABP and CBFV 
(Kashif et al. 2014) ....................................................................................................................... 40 
Equation 3: Height correction factor ............................................................................................. 41 
Equation 4: Calculation of IJV blood flow. .................................................................................. 41 
xi 
 
List of Acronyms  
 
SANS: Spaceflight Associated Neuro-ocular Syndrome  
NASA: National Aeronautics and Space Administration   
ICP: intracranial pressure 
ISS: International Space Station 
nICP: non-invasive measurement of intracranial pressure 
HDT: head-down tilt 
CSF: cerebrospinal fluid 
SAS: subarachnoid space  
CBF: cerebral blood flow  
CVP: central venous pressure 
IJV: internal jugular vein(s) 
LST: lumbar spinal tap 
ED: Emergency Department  
ICU: Intensive Care Unit 
CT: computed tomography  
TCD: transcranial doppler  
ONSD: optic nerve sheath diameter  
PI: pulsatility index  
FVd: diastolic flow velocity  
ABP: arterial blood pressure 
CBFV: cerebral blood flow velocity  
CHI: Coded-Hemodynamic Imaging 
JVP: jugular venous pressure 
IIH: Idiopathic Intracranial Hypertension 
MCA: middle cerebral artery  
nICP-TCD: non-invasive measure of intracranial pressure via transcranial doppler  
CPP: cerebral perfusion pressure 
nCPP: non-invasive measurement of cerebral perfusion pressure 
JVA: jugular venous attenuation 




1.0 BACKGROUND/LITERATURE REVIEW 
1.1 Preamble: Monitoring ICP to assess the risk of SANS in long-duration spaceflight 
Spaceflight Associated Neuro-ocular Syndrome (SANS) occurs in 38-51% of long-
duration astronauts and consists of changes in visual acuity, as well as ophthalmic changes such 
as papilledema, optic nerve globe flattening, optic nerve sheath distention, cotton-wool spots, and 
choroidal folds (Stenger et al., 2017). The National Aeronautics and Space Administration 
(NASA) has defined SANS as one of the top-risks to deep space exploration (Febus, 2019).  
 
Figure 1: The risk matrix for Spaceflight Neuro-Ocular Syndrome (SANS) during various phases 
of space exploration. Note that for “Deep Space Journey/Habitation” and “Planetary” the SANS 
risk still requires mitigation. This refers to the idea that SANS must be solved before, for 
example, astronauts can travel to Mars. Credit: Febus, 2019 
While the etiology of SANS is unknown, current hypotheses focus on the cephalad fluid 
shifts that occur in microgravity environments. It is hypothesized that this fluid shift results in an 
increase in intracranial pressure (ICP) within the skull, which is then transmitted onto the optic 
structures resulting in the documented optical changes post-spaceflight. These physical changes 
are proposed to result in changes in visual acuity (Mader et al., 2011). Changes in optic structures 
can be tracked in space, like many physiological changes, by utilizing in-flight measurements 
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performed by the astronaut with guidance from experts on the ground. However, current 
technological ability has made testing ICP in space near impossible. Currently, the gold standard 
for ICP measurements is invasive catheterization of either the lateral ventricle of the brain 
(intraventricular catheter) or the spinal canal through the lumbar spinal tap (LST) (Raboel, Bartek, 
Andresen, Bellander, & Romner, 2012). Both above methods require instrumentation by medical 
professionals and involve risk of potentially life-threatening complications, making invasive ICP 
measurements inaccessible in practice during spaceflight. Although multiple non-invasive ICP 
(nICP) measurement methods have been suggested, few have been validated. Measurement of the 
optic-nerve sheath diameter (ONSD) via ultrasound has only recently been validated as an accurate 
method to track ICP changes, although a true absolute ICP value (in mmHg) is still not obtained 
(Ohle, McIsaac, Woo, & Perry, 2015). While using ophthalmic ultrasound to obtain a nICP is 
promising to test SANS hypotheses, ultrasound measurements of the eye still require contact with 
the eyelid, a trained operator to guide the astronaut through the measurement and valuable crew-
time for setting up, running, and taking down the experiment. This means that limited 
measurements can be done on a 6-month mission to the ISS. A non-contact, continuous imaging 
modality may provide a better sense of the time course of ICP changes in a microgravity 
environment, as well as provide information on how those changes in ICP are related to ophthalmic 
changes leading to SANS in astronauts.  
In order to improve our understanding of ICP measurement and its surrogates, this thesis 
will employ a microgravity analog for testing new methods of assessing the consequences of 
cephalad fluid shifts and its relevance to cerebrovascular health. The remainder of this literature 
review is focused on how ICP affects cerebral and optic health, current methods of nICP, the use 
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of head-down tilt (HDT) as a microgravity analog for measuring ICP, and a newly developed non-
contact cardiovascular monitoring technology – Coded-Hemodynamic Imaging (CHI). 
1.2 Intracranial Pressure 
 The average ICP for a healthy adult while lying supine is 7-15 mmHg, and while upright 
is -10 mmHg (Czosnyka & Pickard, 2004). According to the Monro-Kellie Doctrine, ICP is made 
up of three components: the brain tissue, cerebrospinal fluid (CSF) and intracranial blood volume. 
The Monro-Kellie Doctrine also states that the sum of these three components must remain 
constant to maintain ICP. An increase of one component must be met by an equal decrease in one 
or both components; when this does not occur, ICP increases. Tissue volume only increases with 
the occurrence of brain tumors, and therefore, changes in ICP are mainly dictated by changes in 
intracranial blood volume and CSF resulting in the following: 
𝐼𝐶𝑃 =  𝐼𝐶𝑃𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟  +  𝐼𝐶𝑃𝐶𝑆𝐹    
Equation 1: ICP as defined by Monro-Kellie 
ICPvascular is determined by the volume of blood within the arterial and venous systems and 
ICPCSF is determined by the CSF volume located within the ventricles and subarachnoid spaces 
(SAS) (Kasprowicz, Lalou, Czosnyka, Garnett, & Czosnyka, 2016).  There is 100-150 mL of blood 
volume located intracranially at all times, of which 40% is located within the venous system 
(Wilson, 2016). According to Davson (Davson, Hollingsworth, & Segal, 1970), increases in 
central venous pressure (CVP) and venous outflow have a more profound effect on ICP compared 
to mean arterial blood pressure (MAP) or cerebral arterial blood volume. Dural sinus pressure is 
often considered to be equal to CVP, as the internal jugular veins (IJV) act as a Starling-resistor, 
meaning they narrow or collapse at the entrance of the dural sinuses, and can transmit CVP directly 
to the dural sinuses.  
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 Currently, the gold standard assessment of ICP is measurement using an intraventricular 
catheter (Tavakoli, Peitz, Ares, Hafeez, & Grandhi, 2017). In order for an intraventricular catheter 
to be inserted, a burr hole is drilled into the skull and the catheter is inserted through the brain into 
either of the lateral ventricles. However, intraventricular catheterization presents a high-risk of 
ventricular infection, with the average rate of infection being 8.8% (Lozier et al., 2002). Epidural, 
subdural, subarachnoid or intraparenchymal catheters can also be placed (see Figure 2), however, 
they carry similar invasive risks (Dimitriou, Levivier, & Gugliotta, 2016) and therefore 
catheterization to monitor ICP is only utilized when absolutely necessary.  
 
Figure 2: Placement for different methods of invasive ICP monitoring.  These methods of 
measuring ICP are considered gold standard to non-invasive meseaurments of ICP. Adapted 
from Rivera-Lara et al., (2017).  
Another commonly used method of measuring ICP is use of an LST, a catheter inserted 
between two lumbar vertebrae into the SAS of the spinal cord. Like using intracranial catheters, 
LST carries a 2-4% risk of infection. Due to the risk involved with performing both intracranial 
catheterization and LST catheterization, invasive measures of ICP cannot ethically be performed 
in healthy subjects during research. This means that the majority of research looking at ICP 
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involves only clinical patients who are already receiving ICP monitoring for another reason, 
leaving a large gap in the knowledge of ICP in the healthy population. In addition, invasive 
measures of ICP must be done in hospital with a physician present, limiting access not only for 
research, but also for patients in remote environments. This has led to the need to develop validated 
nICP methods. 
ICP is an important component of overall brain health and is well studied especially in the 
clinical population. If ICP becomes increased to a level higher than MAP, cerebral perfusion 
pressure (CPP) will drop to zero resulting in death (Cushing, 1901; Rosner & Wood, 1987). Minor 
but chronic increases in ICP can also have serious health consequences, such as in cases of 
Idiopathic Intracranial Hypertension (IIH) where ICP is only slightly elevated above 15  mmHg 
(Smith, 1985). A major morbidity of IIH is visual impairment and ophthalmic changes, which may 
not start to occur until weeks or months after ICP has increased. Visual impairment symptoms 
include visual acuity loss, double vision, blind spots and flashes of lights. Ophthalmic changes 
include progressive papilledema, optic globe flattening, and ONSD increases (Wall, 2010). Both 
the visual impairment symptoms and the ophthalmic changes observed in IIH are like those 
observed in astronauts with SANS (Hamilton et al., 2010). In addition, headaches are often 
reported in patients with IIH due to the increased ICP (Wall, 2010). It is currently unknown if 
headaches reported by 70% of astronauts while on the ISS are due to an increase in ICP, or due to 
other factors such as the cephalad fluid shift resulting in congestion, increased CO2 or constant 
noise which is present on the ISS (Hamilton et al., 2012), although it appears that headaches 
experienced while in space do not have the same chronic nature as those headaches experienced 
by IIH patients on Earth (Mader et al., 2011; Stenger et al., 2017). A non-invasive, non-contact 
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measure of nICP could easily detect these small but important increases in ICP earlier and without 
any of the risk associated with invasive ICP measures.  
While ICP cannot be measured during spaceflight, ICP measurements via LST are completed 
in some astronauts pre- and post- flight. Mader et al., (2011) found that ICP was elevated in 5 of 
the 7 astronauts that completed the study, all of which also had changes in visual acuity or 
ophthalmic changes. One astronaut had a lumbar opening pressure of 28cmH2O (20.5mmHg) 12 
days post-flight, while another had a lumbar opening pressure of 21cmH2O (15.5mmHg) 19 days 
post-flight suggesting that not only is ICP possibly elevated in space, but that it can also remain 
elevated (Mader et al., 2011). However, during a case study of a 45-year old male who spent 6-
months in space, 7-days post-flight lumbar opening pressure was elevated to 22cmH2O (17mmHg) 
and lumbar opening pressure had returned to 16 cmH2O (11 mmHg) 1-year after spaceflight 
(Mader et al., 2017). This crewmember did not experience any changes in visual acuity for the 
duration of the mission (Mader et al., 2017). Changes in visual acuity are not observed in all 
astronauts during spaceflight, and similarly, not all astronauts may have an increase in ICP when 
exposed to microgravity (Mader et al., 2017, 2011) introducing ambiguity into the microgravity-
related SANS etiology hypothesis.  
Until recently, no invasive ICP measurements had ever been completed while in microgravity. 
Lawley et al. (2017) studied 8 patients with an Ommaya reservoir, an intraventricular catheter 
system allowing for direct ICP measurements, during a parabolic flight which allows for 
successive 20-30 second exposures to microgravity. It was shown that during acute bouts of 
microgravity, ICP decreased by 20% compared to resting supine values but did not decrease to the 
level of resting upright values (See Figure 3) (Lawley et al., 2017). While the ICP decrease during 
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acute exposure to microgravity was not expected, it is important to remember that humans spend 
2/3 of the day upright and only 1/3 of the day supine. 
 
Figure 3: Intracranial pressure during parabolic flight. Intracranial Pressure (ICP) was shown to 
decrease compared to supine values in patients fitted with an Ommaya reservoir during the 
microgravity phase of parabolic flight. Adapted from Lawley et al. (2017) and the European 
Space Agency (ESA). 
Therefore, overall mean daily ICP would still be increased in microgravity (Lawley et al., 2017). 
In addition, while the 30 second microgravity periods during parabolic flights can give insight into 
acute changes that occur in microgravity, more evidence is needed in order to make conclusions 
about how ICP changes over longer-durations of spaceflight. The development of a non-contact, 
continuous nICP method would provide insight into how ICP changes over long periods of time 
in microgravity.  
1.3 Non-Invasive Measures of Intracranial Pressure 
Recently, there has been increased focus on developing non-invasive methods of measuring 
ICP, due to the risk of invasive measurements as well as the need for ICP measures in extreme 
remote locations such as the ISS. Various methods of measuring nICP have been proposed. In a 
clinical setting, computed-tomography (CT) scans have been validated against interventricular 
catheterization to give an indication of increased ICP but are difficult to access in remote 
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environments and for research purposes (Komut et al., 2016). More portable measures of nICP 
that have been developed include transcranial-Doppler (TCD)-based measurements and 
measurements based off the ONSD. TCD-based methods of nICP (nICP-TCD) and non-invasive 
measures of cerebral perfusion pressure (nCPP) prediction are based on the pulsatility index (PI) 
derived from TCD and mathematical models. Homburg, Jakobsen, & Enevoldsen (1993) 
suggested that PI and ICP were correlated (r=0.84) when they measured patients with elevated ICP 
who were undergoing mannitol infusion. Similarly, in a study with 81 patients who were receiving 
ICP monitoring for various reasons, PI was correlated with ICP when ICP was between 5 mmHg 
and 20 mmHg (r=0.938) with a sensitivity of 0.83 and a specificity of 0.99 for detecting an ICP > 
20 mmHg (Bellner et al., 2004). However, this is highly contrary to other studies which found little 
to moderate correlation between PI and ICP (Behrens et al., 2010; Rainov, Weise, & Burkert, 2000; 
Zweifel et al., 2012). Predictions based on calculating nCPP are reliant on the assumption that 
nICP=MAP-nCPP. While there are multiple methods of calculating nICP from nCPP, most have 
poor correlation with invasively measured ICP (Cardim et al., 2016; CRobba et al., 2015). Lastly, 
utilizing TCD allows prediction of nICP through different mathematical models. The most studied 
of these mathematical models is the Schmidt Black Box model. Schmidt, Klingelhöfer, Schwarze, 
Sander, & Wittich (1997) created a model based on arterial blood pressure (ABP) and cerebral 
blood velocity (CBV), drawing datasets from reference patients with traumatic brain injury. While 
this model originally appeared to have a strong association to ICP (r=0.73) (Schmidt et al., 2000) 
other research (Cardim et al., 2016; Cardim et al., 2015) found only weak associations between 
the Schmidt Black Box model and ICP (r=0.39, r=0.30). Recently, an algorithm has been 
developed by Kashif, Heldt, & Verghese (2014) using ABP and CBV which does not require 
reference data or calibration to estimate nICP. The nICP-TCD Heldt equation was validated using 
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retrospective data from 37 traumatic brain injury patients who had simultaneous ventricular ICP, 
brachial ABP and TCD CBV measurements. The Heldt equation to predict nICP-TCD was 
strongly correlated with unilateral ventricular ICP measures (r=0.90) with a standard deviation of 
error of 1.6mmHg (Kashif et al. 2014). However, despite the high correlation, sensitivity and 
specificity are low (83% and 70% respectively) (Karshif et al. 2014). While sensitivity and 
specificity could be improved, in comparison to other methods that attempt to predict ICP from 
TCD measures, the Heldt method appears to be the best at predicting ICP (Cardim et al. 2016). 
Limitations exist for using nICP-TCD, including that estimating nICP-TCD can be difficult if 
optimal CBV signal is not able to be acquired. This can be due to anatomical difference in 
approximately 15% of the population, in which the acoustic window is inaccessible (Purkayastha 
& Sorond, 2012). 
The optic nerve sheath is shaped from the three meninges layers of the brain; the dura 
mater, arachnoid mater, and pia mater. The optic nerve, as well as the central retinal artery and 
vein run through the center of the optic nerve sheath. 
 
Figure 4: The anatomy of the Optic Nerve Sheath (ONS). The ONS is made up of the Dura 
mater, Arachnoid mater and Pia Mater, and includes a subarachnoid space (SAS). Adapted from 
Barral & Croibier (2009). 
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The optic nerve sheath is approximately 40 mm long and extends through both the intracranial 
space as well as outside the skull in the orbital space and has an average diameter of ~ 4 mm when 
no intracranial or orbital pathology is present (Zhang & Hargens, 2018). The optic nerve sheath 
also contains a SAS that is continuous with the SAS of the cranium, which is filled with CSF. 
Since the optic nerve SAS is both intracranial and interorbital, the CSF within the optic nerve SAS 
has the ability to transmit ICP onto the optic nerve, where the pressure transmitted through the 
optic nerve SAS via CSF may cause a physical expansion of the optic nerve SAS. Studies in both 
living human subjects and cadavers by Helmke & Hansen (1996) showed that the optic nerve SAS 
could not be visualized by ultrasound, even when forcefully expanded using gelatin in human 
cadavers, however, the ONSD could be visualized easily (Hansen and Helmke, 1996). They found 
that the ONSD increased as the amount of gelatin inserted into the cadavers increased, suggesting 
that ONSD could reflect changes of volume and pressure within the optic nerve SAS (Hansen and 
Helmke, 1996). Hayreh (2016) increased ICP in Rhesus monkeys using an intracerebral balloon 
supporting the notion that as ICP increased, CSF pressure increased and optic disc edema occurred, 
confirming that ICP can be “communicated” through the optic nerve sheath and to the structures 
of the back of the eye. However, in response to an increase in ICP, the ONSD does not increase 
equally along its entire length. The most expansion occurred approximately 3 mm behind the 
globe, with the least amount of change occurring between 6-12mm (Helmke & Hansen, 1996; Ohle 
et al., 2015) 
 The optic nerve SAS, and therefore ONSD, expands in response to varying ICP, and can 
be regarded as a non-invasive outcome that can be examined with clinical ultrasound. Due to this, 
ONSD measurement has become a well researched indicator of raised ICP in both clinical settings 
as well as in analogs of microgravity (Amini et al., 2013; Gangemi, Cennamo, Maiuri, & 
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D’Andrea, 1987; Marshall-Goebel et al., 2017; Tayal et al., 2007). Ultrasound measurements of 
the ONSD are done by placing a linear probe on the eyelid of a closed eye. This allows 
visualization of the globe and the intraorbital portion of the ONS. Callipers can then be placed in 
order to measure the ONSD (See Figure 5). 
 
Figure 5: The process of obtaining optic nerve sheath diameter (ONSD) using ultrasound. A) 
How the eye globe and optic nerve ONSD are visualized using ultrasound. B) How the eye globe 
and ONSD appear when visualized with ultrasound. White lines indicate where ONSD 
measurements are being taken using calipers, in this case 3 mm behind the globe. Adapted from 
Tayal et al. (2007) and Sirek et al. (2014). 
Early clinical research found that ONSD increased proportionally to ICP in patients who were 
being continuously monitored for suspected intracranial hypertension (Gangemi et al., 1987). It 
was also shown that the increase in ONSD was the first ophthalmic sign to appear in cases of 
increased ICP, and treatment to reduce ICP also resulted in a decrease in ONSD (Gangemi et al. 
1987). ONSD has been found to be associated with intraventricular, LST and CT ICP measures 
(Amini et al., 2013; Hansen & Helmke, 2009; Kimberly, Shah, Marill, & Noble, 2008; Komut et 
al., 2016; M., D., & PR., 2001). In addition, ONSD has a strong sensitivity and specificity for 
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detecting ICP >15 mmHg (Amini et al., 2013; Kimberly, Shah, Marill, & Noble, 2008; Kishk, 
Ebraheim, Ashour, Badr, & Eshra, 2018; Rajajee, Vanaman, Fletcher, & Jacobs, 2011; Tayal et 
al., 2007). A systematic review completed by Ohle et al., 2015 looking at 12 studies focusing on 
results gained from the emergency department (ED) or intensive care unit (ICU) suggested that 
the raised ICP threshold (ICP > 15 mmHg) should be ONSD > 5 mm. The threshold of ONSD > 
5 mm resulted in a sensitivity of 95.6% and a specificity of 92.3% (Ohle et al. 2015).  
Overall, evidence suggests that changes in ONSD can be a surrogate indicator for changes 
in ICP in both clinical and microgravity analog studies when compared to either invasive ICP 
measures or nICP measures. Preliminary application studies also indicate ONSD increases in some 
astronauts, suggesting that ICP may be increased, although ICP has not been measured at the same 
time for comparison in microgravity (Sirek et al., 2014). While ONSD may be able to indicate 
changes in ICP, ONSD measurements require training, contact with the skin and valuable time to 
complete scanning, and is therefore unable to track continuous changes in ICP. Non-contact, 
continuous monitoring methods of tracking changes in ICP would be beneficial in both clinical 











Table 1: Summary of clinical results comparing ONSD to ICP. 
Author Year Patient condition  Main Findings 
Gangemi et 
al., 
1987 Intracranial Hypertension  
ONSD increased and decreased 







Linear covariance between ONSD and CSF 
pressure (r=0.78) 
 






Average ONSD was 6.27 mm when CT 
evidence of increased ICP was present 
Tayal et al., 2007 Acute head injury 
ONSD >5 mm corresponded with CT 




Receiving ICP monitoring 
as part of their care plan 
ONSD correlated with intraventricular ICP 
(r=0.59) 
 
ONSD >5.0 mm has a sensitivity of 88% 
and a specificity of 93% for detecting ICP 
>20 H
2




 Non-traumatic patients 
eligible for LST 
ONSD correlated with ICP (r=0.88) 
 
ONSD >5.5 mm has a sensitivity and 
specificity of 100% for detecting ICP >20 
H
2




Admitted to ICU for 
intraventricular ICP 
monitoring 
ONSD >4.7 mm has a sensitivity of 95% 







ONSD had low correlation with CT 
evidence of increased ICP (r=0.36) 
 
ONSD >5.3 mm has a sensitivity of 70% 
and a specificity of 74% for detecting CT 
evidence of ICP >20 mmHg 
Kishk et al., 2018 
Idiopathic intracranial 
hypertension 
ONSD >6.05 mm has a sensitivity of 73.2% 
and specificity of 91.4% for detecting ICP 
>20 H
2




Figure 6: Location of ONSD, nICP-TCD, IJV CSA and CVP measurements compared to 
invasive ICP measurements. Adapted from Rivera-Lara et al., (2017), Biorender and 
AnatomyZone. 
1.4 Jugular Vein Cross-sectional Area, Central Venous Pressure and Intracranial Pressure 
The venous system is a passive conduit system in which blood is collected and moved back 
toward the heart through a low-pressure differential. Venous blood in the brain is collected into 
the sagittal, straight, and transverse sinuses, the largest of which are the sagittal sinuses. These 
sinuses are suspended within the dura mater which gives them the ability to not only collapse, but 
to also carry negative pressure when venous over drainage occurs, something that cannot be done 
by the rest of the human vasculature. At any one time, there is approximately 100-150 mL of blood 
within the cerebral vasculature; 40% of this blood volume lies within the venous sinuses (Wilson, 
2016). Total blood volume is a large determinate of ICP, as discussed above. Cerebral venous 
blood flows passively back toward the heart via one of two major pathways, dependent on posture 
(Gisolf et al., 2004). While upright, the majority of cerebral venous blood flows out of the vertebral 
veins whereas in the supine posture, the majority of cerebral venous blood flows toward the heart 
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through the IJVs (See Figure 7). The difference in cerebral venous blood outflow with different 
postures is due to the collapsibility of the IJV. In the upright posture, the sagittal sinus has a 
negative pressure, and therefore the IJV will collapse in order to protect the brain from incurring 
a greater negative pressure (Luce, Huseby, Kirk, & Butler, 1982).  
 
Figure 7: Venous anatomy of the cerebrum and neck. Adapted from da Silva, Gonçalves, & de 
Loiola Cisneros (2017) 
Blood flowing through the IJV creates jugular venous pressure (JVP), of which the waveform can 
indicate changes in cardiac function (See Figure 8) (Applefeld, 1990). JVP is also heavily 
influenced by CVP, which is considered to be identical to right atrial pressure. Both JVP and CVP 
are determinants of preload and are influenced by blood volume, and therefore decrease when 
upright. However, increased JVP, IJV CSA, and CVP can all be indicators of increased cerebral 




Figure 8: The jugular venous pulse waveform has 5 distinct characteristics (a) an increase in 
pressure before systole from right atrial contraction , (c) a further increase in pressure due to 
ventricle contraction, (x) a sharp decrease in pressure during systole and during atrial filling, (v) 
a small increase in pressure at the end of systole when atrial is nearing full and, (y) a decrease in 
pressure as the tricuspid valve opens and ventricular filling begins Adapted from Amelard et al., 
(2017). 
Impedance of cerebral venous outflow, also known as venous congestion, can cause an 
increase in ICP. Davies, Deakin, & Wilson (1996) found that placement of a rigid cervical collar 
on patients increased ICP, on average by 4.5 mmHg, but did not increase MAP suggesting that the 
increase in ICP was due to alteration of cerebral venous outflow. Similar results were found by 
Stone et al., (2010) who found that IJV CSA increased by an average of 37% after placement of a 
rigid cervical collar in 42 healthy subjects. It was concluded that the increase in IJV CSA was an 
indication of venous congestion, and therefore contributes to an increase in ICP, although ICP was 
not measured (Stone et al., 2010).  In addition, vertebral vein outflow does not increase to 
compensate for decreased IJV outflow, possibly augmenting the amount of venous congestion 
(Ciuti, Righi, Forzoni, Fabbri, & Pignone, 2013; Ogoh, Sato, Abreu, Denise, & Normand, 2019). 
Venous congestion can be caused simply by changing neck position (Lawley et al., 2017; 
Mavrocordatos, Bissonnette, & Ravussin, 2000). During intracerebral surgery where ICP was 
continuously monitored, it was shown that any non-neutral neck position resulted in an increase in 
ICP, most notably when the neck was in a flexed position turned to the right or left, inhibiting 
normal venous outflow (Mavrocordatos et al., 2000). Constriction of the IJV results in impedance 
of cerebral venous outflow, which in turn increases ICP. 
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IJV CSA has also been investigated during spaceflight. IJV CSA was found to increase 
from 1-week up to 6-months of spaceflight (Arbeille et al., 2001; Marshall-Goebel et al., 2019). 
Similarly, IJV volume was found to increase up to 225% of on-Earth baseline after 135-days of 
spaceflight (Arbeille, Provost, Zuj, & Vincent, 2015). IJV volume returned to baseline values 4-
days after re-introduction to gravity, suggesting that, during spaceflight, that there is a passive 
storage of blood in the cephalic area that causes blood stagnation or reverse blood flow and venous 
congestion, which may contribute to increased ICP (Arbeille, Provost, Zuj, & Vincent, 2015; 
Marshall-Goebel et al., 2019). Overall, increased IJV CSA, venous congestion and IJV volume 
appear to contribute to an increase in ICP and may be able to be used as an indicator of increased 
ICP.  
CVP may also be able to give an indication of ICP. CVP gives an indication of right atrium 
pressure and is a determinant for filling pressure (preload) of the heart. Therefore, CVP can also 
give an indication of venous compliance and blood volume. Resting CVP is normally 5-15 mmHg 
supine and 2-6 mmHg upright. When upright, CVP is not transmitted to the dural sinuses but when 
supine the IJV transmits CVP directly to the dural sinuses. However, CVP does influence IJV CSA 
and flow (Gisolf et al., 2004; Lawley et al., 2017). While upright, the IJV is collapsed and therefore 
has no flow; however, by increasing CVP through a Valsalva manoeuvre, IJV CSA increases and 
IJV blood flow is restored (Gisolf et al., 2004). Increases in CVP and IJV pressure have also been 
shown to directly influence ICP. Bedford (1935) increased IJV pressure in dogs by clamping 
closed the JV. It was found that this JV obstruction resulted in an instant increase in cerebral 
venous pressure and CSF pressure which subsequently was concluded to have also increased ICP 
(Bedford, 1935). Interestingly, this increase in JV pressure and CSF pressure remained even 60 
minutes after the obstruction was removed. Similarly, CVP was manipulated in Yorkshire pigs by 
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inserting saline directly into the venous system while ICP was continuously measured in the 
ventricle (Hamilton et al., 2011). It was found that CVP and ICP have a linear relationship, and 
that change in CVP alone can result in a change in ICP (Hamilton et al., 2011). Considering this, 
the ability to track changes in IJV pressure or CVP pressure non-invasively may also allow for 
non-invasive tracking of ICP. 
During HDT, CVP is initially increased, similar to ICP, due to the cephalad fluid shift that 
HDT evokes (Lawley et al., 2017). However, after 3-4 hours in HDT, blood volumes begin to 
significantly decrease due to cardiovascular adaptation (Fischer, Arbeille, Shoemaker, O’Leary, 
& Hughson, 2007). Due to this decrease in central blood volume, CVP also decreases after only 
4-hours in 6° HDT (Edgell, Grinberg, Gagné, Beavers, & Hughson, 2012; Lawley et al., 2017). 
This is unlike spaceflight where CVP initially decreases (Buckey et al., 1996).  The decrease in 
CVP, despite the same cephalad fluid shift, is due to the unloading of the chest wall allowing for 
increased passive filling of the heart and central veins. During parabolic flight, which includes 
short 30-second periods of microgravity, CVP decreases (Lawley et al., 2017; Martin et al., 2016). 
In patients with Ommaya reservoirs inserted, allowing for direct ICP measurements, the decrease 
in CVP during parabolic flight corresponded with a decrease in ICP (Lawley et al., 2017).  An 
increase in CVP invoked by a Valsalva maneuver also increased JVP during parabolic flight, 
suggesting that increases in CVP may result in an increase in JVP and a reduction in cerebral 
venous outflow (Martin et al., 2016). Although CVP has been studied in acute and short-duration 
spaceflight, no CVP measurements have been made past 48-hours in microgravity. Like ICP, 
measuring CVP is an invasive procedure that currently carries a greater than acceptable risk for 
measurements on the ISS. Due to this, there is no information on how CVP or JVP may change 
with longer-duration spaceflight, and how CVP and JVP may relate to ICP in the microgravity 
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environment. Overall, changes in CVP and JVP in HDT and short-term spaceflight appear to 
correspond to changes in ICP. However, due to the invasive nature of these measures, long-term 
data are not available. The ability to non-invasively track changes in CVP through non-contact 
CHI imaging may also have the ability indicate changes in ICP. 
1.5 Coded Hemodynamic Imaging 
 Coded Hemodynamic Imaging (CHI) is a novel zero-effort, non-contact cardiovascular 
monitoring device developed at the University of Waterloo. CHI is a photoplethysmographic 
imaging system which utilizes a near-infrared sensitive camera and a near-infrared illumination 
source for subsurface optical hemodynamic assessment (Amelard et al., 2017). By processing the 
signal gained through the infrared light’s interaction with the tissue, it is possible to derive various 
cardiovascular outcomes such as heart rate (Amelard et al., 2015), blood pressure (Amelard, 
Clausi, & Wong, 2016),  arterial oxygenation (Millikan, 1942; Tran, Amelard, & Wong, 2017), 
common carotid artery pressure/waveforms, IJV pressure/waveforms (Amelard et al., 2017), and 
IJV volume, although not all of these have completed testing with CHI to date.  
 
Figure 9: Coded-Hemodynamic Imaging (CHI) system. CHI camera set up showing how the 
optics, processing and camera are housed together.  
CHI works by illuminating an infrared light source directly over the area of interest. Infrared light 
is able to penetrate the tissue to the level of the superficial vascular and arterial systems. The level 
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of light, or signal, returned to the surface will vary depending on the amount of blood volume in 
the vessel, specifically hemoglobin within the blood (Amelard, 2017; Jacques, 2013). Since 
superficial arteries and veins are pulsatile, the amount of blood within the vessel at any given time 
will fluctuate, which is mirrored in the light absorption signal. The signal fluctuations are captured 
using the camera, and pixel intensities are converted to optical attenuation using an optical model 
(Amelard et al., submitted). During signal processing, pixels from the video are treated as “virtual 
sensors”. For example, using a 1-megapixel camera allows an extraction of blood flow from up to 
1 million virtual sensors across the field of view. Signal processing is done based on the Beer-
Lambert law, which compares the infrared light output to the amount of light (signal) that is 
returned to the infrared camera. After the signal is processed, spatiotemporal assessment can be 
completed to look at how the blood volume changes over time.  
 
Figure 10: An overview of how CHI derives information. Adapted from Amelard et al. 2017 
CHI has demonstrated the ability to evaluate the JVP waveform. In a recent study by Amelard et 
al., (2017), 24 participants underwent testing which compared CHI signals assessed from the neck 
region (See Figure 10) to simultaneous finger photoplethysmography measurements. CHI was able 
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to estimate two distinct pulsatile signals, which were established to be from the common carotid 
artery and IJV via ultrasound. It was found that the signals corresponded strongly to both the 
arterial (r=0.85) and “inverted” (venous) signal (r=0.73) measured by finger 
photoplethysmography (See Figure 11).  
 
Figure 11: Individual data showing the JVP waveform (black line) evaluated by CHI compared 
directly to the finger photoplethysmography arterial waveform. Adapted from Amelard et al. 
2017 
In addition, visually, the inverted processed CHI signal and the JVP waveform are similar (See 
Figure 12) (Applefeld, 1990). The JVP waveform is a clinical indicator of cardiac function that 
normally requires invasive catheterization of the jugular vein. Similar to ICP, the invasive nature 
of the catheterization acts as a barrier for assessment, and therefore is only done in acute care 
environments. CHI’s ability to non-invasively detect this waveform establishes its ability to 




Figure 12:  JVP waveform detected by CHI (blue) compared to the classical JVP waveform. 
Adapted from Amelard et al. 2017. 
  Pilot work on a single subject in 2018 was done to test the CHI’s robustness to detect the 
IJV pulse while in an approximate 8° HDT position. The signal garnered from the CHI was 
compared directly to CVP, which was measured via catheterization of a vein in the antecubital 
fossa. Unpublished results (Amelard et al.,) show that the CHI was able to demonstrate IJV 
pulsitility which closely matched CVP in both the supine and 8° HDT position. While only from 
a single subject, these results show that CHI does have the ability to garner accurate IJV pulse 
signals compared to catheterized CVP measures in both supine and in an HDT position.  
 
Figure 13: Pilot data directly comparing CHI IJV pulsatility to CVP over 30s in both supine 
position and 8° HDT position. From Amelard et al. (Unpublished). 
Ongoing testing has increased confidence of the CHI’s ability to track changes in JVP and CVP. 
In 19 healthy subjects (9 Female, 25±5 years, 170±10 cm, 67±12 kg) undergoing CHI and CVP 
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measurement simultaneously during supine, 2.7° HDT and 5.4° HDT, mean CHI signal intensity 
strongly correlated with mean CVP (rrm=0.75) (Robertson & Amelard., Unpublished). Visual 
analysis of the CHI derived pulse compared to CVP indicates that CHI is able to track changes in 
CVP pulsatility across multiple HDT angles (See Figure 13 and 14).  
 
Figure 14: Internal jugular vein (IJV) cross-sectional area (cyan), central venous pressure, and 
Coded-Hemodynamic Imaging (CHI) intensity (arbitrary units) from IJV measured at supine, 
2.7°, and 5.4° head-down tilt. 
In addition to being able to derive the IJV pulse, CHI can detect “biomarkers” for changes in 
hemoglobin content, and therefore can also give an indication of volume changes. Ongoing testing 
has indicated a moderate relationship between mean IJV CSA measured via ultrasound and jugular 
venous attenuation (JVA) measured by CHI at supine, 2.7° HDT and 5.4° HDT (rrm=0.52) 
(Robertson & Amelard., Unpublished). Ultrasound is often used as a non-invasive way to measure 
IJV CSA, which can be analyzed to give an approximate volume at that given image point. 
Ultrasound also has the ability to measure IJV velocity and pulsatility non-invasively. However, 
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unlike CHI, ultrasound requires a trained operator, contact with the skin and a certain amount of 
time to conduct the test. Traditional ultrasound systems make it difficult to continuously collect 
data about physiological variables over time, something CHI does have the ability to do.  
1.6 Head-Down Tilt as a Microgravity Analog  
The ability to perform experimental protocols in true microgravity is limited due to the high-
cost and limited resources associated with microgravity research. Microgravity analogs were 
established to mimic the physiological effects of microgravity on Earth, in order to study 
microgravity effects with low resource costs, for controlled periods of time, while controlling for 
confounding factors such as physical activity, diet, and sleep. One of the most common 
microgravity analogs is HDT, a manoeuvre where a person lying supine is tilted from a horizontal 
position to a position where the head is below the legs (Hargens & Vico, 2016; Watenpaugh, 2016) 
which was established as a valid microgravity analog early on in space exploration (Kakurin, 
Kuzmin, Matsnev, & Mikhailov, 1976; Krupina, Fyodorov, Filatova, Tsyganova, & Matsnev, 
1976). 
HDT angles from 4° to 20° have previously been tested to determine which angle best 
approximates the physiological changes observed in microgravity (Kakurin et al., 1976; Krupina 
et al., 1976). Six-degrees HDT causes similar cardiovascular outcomes, such as heart rate, blood 
pressure, cardiac output, blood volume and cardiac mass (Arbeille et al., 2001; Fischer et al., 2007; 
Platts et al., 2009) and musculoskeletal unloading observed in microgravity and could be 
considered the most commonly used HDT angle in microgravity research (Watepaugh, 2016). 
However, studies utilizing 6° HDT have not been able to reproduce the same ophthalmic findings 
observed in microgravity, nor the expected ICP increase. In a series of studies conducted by Taibbi 
et al. (Taibbi, Cromwell, Kapoor, Godley, & Vizzeri, 2013; Taibbi et al., 2014, 2016), 6° HDT 
25 
 
was found to have no effect on vision or intraocular pressure (IOP) and did not induce any 
incidence of edema of the optic nerve (papilledema) at 14-days, 30-days or 70-days of HDT. As a 
result, it has recently been debated if 6° HDT produces a similar amount of cephalad fluid shift as 
observed in microgravity (Hargens & Vico, 2016; Watenpaugh, 2016). It is important to note, that 
in earlier HDT studies, participants were able to prop themselves up on an elbow in order to eat 
throughout the day, disrupting the supposed constant cephalad fluid shift. Participants were also 
allowed the use of a pillow throughout the day, slightly elevating the head. These factors have 
been speculated to contribute to the lack of expected ICP increase in these studies (Lawley et al., 
2017; Petersen et al., 2018).  
 In order to increase the amount of cephalad fluid shift, proof-of-concept SANS studies 
have shifted towards using more severe HDT angles (angles between 9° and 45°), most commonly 
between 9° and 18°, with equivocal ICP and clinical ophthalmic results (Marshall-Goebel, Mulder, 
Bershad, et al., 2017). Clinically, it has been observed that severe HDT results in an increase in 
ICP due to the cephalad fluid shift, as summarized below (Table 2) (Eklund et al., 2016; S. Lee, 
1989; Mavrocordatos et al., 2000; Petersen, Petersen, Andresen, Secher, & Juhler, 2015; Petersen 
et al., 2018).  
In addition, Lawley et al. (2017) measured ICP in 8 patients with an Ommaya reservoir 
already inserted during 24-hours of 6° HDT. An initial increase in ICP was maintained for 3-hours 
before decreasing back to supine values the end of 24-hours (Lawley et al., 2017). Importantly, 
during this protocol Lawley et al. (2017) discovered that the use of a pillow during HDT 
consistently decreased ICP by 4mmHg. Similarly, Petersen et al., (2018) found that a pillow 
decreased ICP by 5.5 mmHg. For ethical reasons, the majority of research looking at ICP only 
involve clinical patients who are already receiving ICP monitoring for another reason. Multiple 
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nICP methods have been developed in order gain insight into ICP in the healthy population, 
however very few have been shown to have an association with invasive measures of ICP.  
Table 2: Summary of findings regarding HDT and ICP. 














ICP increased from 







 30° 20-minutes 
ICP significantly 
increased compared to 
supine resting values. 
 
Increase in ICP was 
further exaggerated 
when neck was in a 
flexed position. 
Petersen et al., 2015 
5 – 
Neurosurgery 





8.9±3.7 mmHg to 
14.6±4.7 mmHg at 10° 
HDT. 
 
ICP further increased to 
20.0±4.7 mmHg at 20° 
HDT. 




ICP increased an 
average of 11 mmHg 
over supine values. 
Eklund et al., 2016 
11 – LST 
monitoring 
9° 5-minutes 
ICP increased to 
15.8±1.3 mmHg from 
10.5±1.5 mmHg in a 
supine position. 
 
Since it is well established that ICP increases as HDT angle increases (Petersen et al., 2015), 
changes in ONSD has been recently studied during surgeries that utilize the Trendelenburg 
position (15°- 45° HDT) . Patients undergoing surgery in HDT >25° have an increase in ONSD 
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(Chin, Choi, Hwang, & Kim, 2014; J. H. Chin et al., 2015; Robba et al., 2016; Shah, Bhargava, & 
Choudhury, 2015). This increase in ONSD was not observed in patients undergoing surgery while 
supine (Shah et al., 2015). In addition, the increase in ONSD corresponded to an increase in nICP-
TCD during 10-minutes of 25° HDT (Robba et al., 2016). Although invasive ICP measurements 
were not made, Chin et al., (2014, 2015) concluded that the increase of ONSD to 5.0 mm suggested 
that ICP >20 mmHg. Generally, it was concluded that ONSD is an ideal way to monitor changes 
in ICP during surgeries in Trendelenburg position (Chin et al., 2014; Chin et al., 2015; Robba et 
al., 2016; Shah et al., 2015). 
Table 3: Summary of findings of ONSD in Trendelenburg position >25° 




Surgery Type Main Findings 
Chin et 
al., 
2014 30° 30 minutes 
laparoscopic radial 
prostatectomy   




2015 35° 3 minutes 
laparoscopic radial 
prostatectomy   
Increase of ONSD from 




2015 45° 3 hours 
laparoscopic radial 
prostatectomy   
Increase of ONSD from 
4.3 mm to 6.3 mm 
Robba et 
al., 
2016 25° 10 minutes 
laparoscopic radial 
prostatectomy   
ONSD and nICP-TCD 
increased 
 
Recently, ONSD has also been studied in various angles of HDT in a non-clinical 
population specifically to simulate the cephalad fluid shift observed in spaceflight. The change in 
ONSD and nICP-TCD was measured in 8-subjects undergoing 6° HDT for 60-minutes. Compared 
to upright sitting, nICP-TCD increased on average from 4.2 mmHg to 11.3 mmHg during HDT 
(Laurie et al., 2017). The increase in nICP-TCD coincided with an increase in ONSD (Laurie et 
al., 2017). Similarly, in a series of studies completed by Marshall-Goebel et al. (2017) nICP-TCD 
and ONSD both increased after 3.5-hours in 6°, 12° and 18° HDT and ONSD increased a greater 
amount at more severe angles of HDT (Marshall-Goebel et al., 2017). Five-minutes of -40mmHg 
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lower body negative pressure, a stimulus used to draw fluid into the legs, was found to have the 
ability to decrease both nICP-TCD and ONSD at the end of 5-hours of 12° HDT, suggesting that 
ONSD mimics changes in ICP (Marshall-Goebel et al., 2017). Likewise, Sirek et al., (2014) found 
that ONSD increased 0.3mm after 20-minutes of 6° HDT and 0.5 mm after 20-minutes of 30° HDT 
compared to supine values. Astronaut ONSD was also looked at pre-, during, and post-flight time 
points in 17 astronauts where ONSD increased approximately 0.9 mm after exposure to 
microgravity (Sirek et al., 2014), suggesting that the fluid shift and therefore ICP change at 30° 
HDT may better reflect what is occurring in microgravity. This agrees with results published by 
Kramer, Sargsyan, & Hamilton (2012) which found that ONSD was increased post-flight in 33% 
of long-duration astronauts. Less-acute HDT angles have also shown to increase nICP values. 
Marshall-Goebel et al., (2017) found that nICP measured via TCD and MRI non-significantly 
increased after 5-hours in both 12° and 18° HDT. Even 10-minutes of 15° HDT was sufficient to 
increase nICP via transcranial pulse measurements (Macias, Liu, Grande-Gutierrez, & Hargens, 
2014). In contrast, 5-hours in 6° HDT does not result in an increase in nICP (Marshall-Goebel et 
al., 2017). Overall, nICP appears to increase in response to a cephalad fluid shift initiated by HDT 
of at least 9°. 
HDT also results in an increase in IJV CSA and venous congestion. IJV CSA increases 
significantly within the first minute of HDT (Clenaghan, McLaughlin, Martyn, McGovern, & 
Bowra, 2005; Schreiber, Lambert, Doepp, & Valdueza, 2002). However, IJV CSA does not 
increase or decrease significantly past the first minute even after multiple days in HDT, suggesting 
that IJV CSA quickly reaches a plateau (Arbeille et al., 2001; Schreiber et al., 2002). In addition, 
IJV CSA increases further as HDT angle is increased, where IJV CSA will be greater at 30° than 
at 6° independent of time in HDT (Clenaghan et al., 2005; Marshall-Goebel et al., 2016, 2018). 
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The increase in IJV CSA coincides with an increase in IJV volume (Arbeille et al., 2017; Marshall-
Goebel et al., 2018) despite a known decrease in central blood volume occurring after four hours 
of HDT due to cardiovascular adaptation (Edgell et al., 2012; Fischer et al., 2007). Reduction of 
blood flow and blood flow velocity also occurs in the IJV with HDT, implying that venous 
congestion prevents the outflow of cerebral venous blood (Marshall-Goebel et al., 2016). In 
contrast, the common carotid artery CSA does not increase until 18° HDT, suggesting that 
increases in ICP associated with a headward fluid shift are due to venous congestion and not 
increased cerebral in flow (Arbeille et al., 2017; Marshall-Goebel et al., 2016). Findings are 
summarized below in Table 4. 
The duration of HDT studies have varied from 10-minutes to 370-days, with the majority 
of studies utilizing an HDT time of 4-hours to 30-days. However, as more severe tilt-angles (9°-
18°) are being employed, shorter time periods of 10-minutes to 24-hours have been preferred. This 
is more similar to clinical research looking at severe HDT (15°- 45°) which often focuses on an 
HDT time between 3-minutes and 30-minutes (Shah, Bhargava, & Choudhury, 2015). The shift 
toward a shorter duration of severe HDT may be due to increased participant discomfort as tilt 
angle increases, rather than methodological advantages. Overall, short-periods of severe HDT 
induces a consistent increase in ICP, ONSD, CVP and IJV CSA that can be related to a cephalad 
fluid shift (Andresen, Hadi, Petersen, & Juhler, 2014; Marshall-Goebel et al., 2018; Petersen, 







Table 4: Summary of findings of IJV CSA in HDT. 







2002 10° 20 minutes 
IJV CSA increases within the first 
minute of HDT but does not 




10°, 15°, 20°, 
25°, 30° 
30 seconds 
IJV CSA increased after 30-seonds 
of HDT 
 
IJV CSA increases as HDT angle 
increases 
Arbeille et al., 2001 6° 
10-hours, 4, 5, 7, 
and 42 days 
IJV CSA remained increased 
through the duration of HDT 
Marshall-
Goebel et al., 
2016 6°, 12°, 18° 4.5 hours 
IJV CSA increased at all HDT 
angles compared to supine values. 
 
IJV blood flow and IJV blood 
flow velocity decreased 




IJV volume increased 
2.21±1.10 mL 
Marshall-
Goebel et al., 
2018 
6°, 12°, 18°, 
24°, 30° 
26 hours 
IJV volume increased at all HDT 
angles compared to supine 
 
IJV volume was greater with 




Raised ICP has been hypothesized to be the cause of SANS in astronauts, which results in 
visual loss and ophthalmic changes. However, current gold standard measurements of ICP are 
extremely invasive and cannot be performed on the ISS, and even validated nICP measurements 
that could be completed on the ISS require additional equipment, a trained operator, contact with 
the skin and take up valuable astronaut time. CHI is a novel tool with promise, which has 
demonstrated the ability to derive in a non-contact way, JVP, which normally requires invasive 
catheterization. Preliminary results indicate that CHI acquires signal (JVA) that is strongly 
associated with CVP and moderately associated with IJV CSA during 2.7° HDT and 5.4° HDT, 
both of which are indicators of ICP. Therefore, utilizing the CVP and IJV volume information 
derived from the CHI signal, it may also be possible to give an indication of ICP. The venous 
information derived from non-contact, zero-effort CHI imaging could be a beneficial surrogate for 
measuring ICP in hostile environments such as microgravity. 
3.0 RESEARCH QUESTIONS, OBJECTIVES AND HYPOTHESES:  
Main Research Questions: Does jugular venous attenuation (JVA), determined by CHI, 
provide sensitive information equivalent to changes in nICP-TCD and ONSD, indicators 
of ICP, during a cephalad fluid shift? How does cerebral vascular outflow change with 




Objective #1: To determine if changes in JVA reflect changes in IJV CSA and CVP, and 
in turn relate to measures of nICP (ONSD and nICP-TCD) in young, healthy adults 
during 12° HDT and 30° HDT.  
Hypothesis #1: JVA will increase with increases in jugular venous volume and CVP 
during HDT. Changes in JVA will correlate to changes in ONSD and nICP-TCD during 
12° HDT and 30° HDT enabling prediction of changes in ICP in a non-invasive, non-
contact method.  
Objective #2: To determine how venous cerebral outflow, via the IJV, is affected by 12° 
HDT and 30° HDT and how these changes relate to measures of nICP. 
Hypothesis #2: IJV blood flow will be attenuated and IJV CSA will be increased at both 
12° HDT and 30° HDT, which will be associated with an increase in nICP. 
 
4.0 GENERAL METHODOLOGY: 
4.1 Ethics and Funding 
The experimental procedure described was approved by the Office of Research Ethics at 
the University of Waterloo (ORE#41287). Funding for this study was provided by the Canadian 
Space Agency’s Flights and Fieldwork for the Advancement of Science and Technology (FAST) 
funding initiative.  
4.2 Recruitment 
Eleven healthy participants were recruited from the community using posters, social media 
and word of mouth. Inclusion and exclusion criteria have been defined in the table below (Table 
5). To define a required sample size, a power calculation (G-Power) was completed using the 
outcome of change in IJV CSA in supine to 12° HDT acquired from Marshall-Goebel et al., (2018), 
which produced a mean difference of 0.22 cm2 and standard deviation of difference of 0.12 cm2, 
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which yielded an effect size of d=1.84. Using an α=0.05 and Power=0.95, the required sample size 
was calculated to be n=7. In order to have equal male and female representation, we doubled this 
sample size, as well as accounted for potential drop out, bringing the recruitment goal to 16 
participants. To determine eligibility, participants were given an eligibility survey prior to being 
consented.  
Table 5: Inclusion and exclusion criteria for “The association of Coded Hemodynamic Imaging 
with markers of blood vessel and eye health during short-duration head down tilt” study. 
Inclusion Criteria Exclusion Criteria 
- Aged 18-55 
 
- History of arterial disease, venous disease, blood clotting 
disorders, stroke, myocardial infarction, heart failure, heart 
valve disease, autonomic failure or rheumatic fever 
- Kidney Disease 
- Liver Disease  
- Chronic Inflammatory Disease  
- Diabetes Mellitus 
- Neurological Disorders 
- Severe Skin Sensitivities 
- Glaucoma  
- Use of steroidal medication 
- History of ocular trauma 
- History of alcohol or nicotine abuse (i.e. chronic smokers)  
- Pregnancy 
- Active Ocular Infection (e.g. redness and discharge) 
- Thyroid Disease 
- Allergy to Latex 
- Allergy (or history of adverse reaction) to anesthetic  
 
 
4.3 Overview and Data Collection 
Participants were asked to come to the Vascular Aging and Brain Health Lab at the Research 
Institute of Aging (RIA). Participants were instructed not to consume alcohol, nicotine, caffeine 
or exercise 12 hours prior to the beginning of testing as well as not to consume any food or drink 
(except water) 2 hours prior to the beginning of testing. The eligibility questionnaire confirmed 
that the participant is within the desired age range of 18-55 as well as determined if the participant 
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has ever been diagnosed with conditions that were included in the exclusion criteria. Certain health 
conditions were excluded from the study due to effects on blood pressure, blood flow, ICP, IOP, 
or the relationship between any of these variables. Cardiovascular conditions affecting blood 
pressure and/or flow can also affect the ability to derive cardiovascular information from CHI. In 
addition, the eligibility questionnaire asked participants if they had ever had an allergic or adverse 
reaction to anesthetic. The study utilized Proparacaine Hydrochloride, a topical anesthetic eye 
drop, and therefore if the participant has a known allergy to anesthetic or had ever had adverse 
reactions (such as vomiting, fainting, etc.) for their safety, they were excluded from participation. 
If the participant was clear from any of the exclusion criteria as indicated by the eligibility 
questionnaire, they were then brought through the process of informed consent, including an in-
depth description of the experimental procedure. A brief health questionnaire was then 
administered asking about medication the participant had taken in the last 24 hours prior to the 
start of testing, as certain medications may impact certain physiological variables (i.e. cold 
medicine may impact heart rate). While sitting upright, participants were fitted with equipment for 
continuous cardio and cerebrovascular monitoring, as well as continuous respiratory monitoring. 
Participants were taken through a protocol consisting of 5 minutes of seated resting measures, 5 
minutes of supine resting measures (baseline), 25 minutes of measures while in 12° HDT, 25 
minutes of measures while in 30° HDT, and 25 minutes of recovery measures after returning to 
supine position (recovery). All measures, except for near-infrared spectroscopy (NIRS), were 




Figure 15: Study diagram. Top numbers represent time in minutes. Alternating blue bars indicate 
5-minute periods Arrows indicate times which CHI, ocular ultrasound and vascular ultrasound 
measurements were acquired. Continuous CVP, TCD, and BP measures were acquired during 
the entire length of the testing. IOP measurements were taken at the end of baseline, 12°, and 30° 
and will be included in a separate study.     
Hemodynamic Monitoring:  
Blood pressure: Participants were outfitted with the Finapres NOVA (Finapres Medical Systems, 
Amsterdam, The Netherlands) for continuous BP monitoring via finger cuff 
photoplethysmography. The Finapres NOVA will also provide estimated brachial (systolic, 
diastolic, mean) BP utilizing frequency dependent filter which transforms the waveform to the 
brachial level. In addition, stroke volume (SV) and cardiac output (Q̇) are calculated using the 
Modelflow algorithm.  
Heart rate (HR): A single-lead electrocardiogram with 3-electrodes continuously measured heart 
rate. Electrodes were placed under the right and left clavicle and on the bottom of the left ribcage. 
The lead was attached to the Phillips clinical ultrasound machine (iE33 xMatrix, Koninklijke 
Philips N.V., Amsterdam, The Netherlands) for monitoring.  
Central venous pressure: CVP was continuously measured from a catheter placed in a vein within 
the right antecubital fossa using the technique previously described by Gauer & Sieker, (1956). 
Briefly, the vein was punctured using a single-use 20G needle attached to a polyurethane catheter 
(SUPERFLASH I.V Catheter, Terumo Corporation, Tokyo, Japan). The catheter was then attached 
to a saline filled single-use pressure monitoring kit (transducer) (TransStar 60in (152cm) single 
monitoring kit, Smiths Medical ASD Inc., Dublin, OH, USA) which was connected into the 
PowerLab/16SP. The pressure transducer was positioned using a laser level to the level of the right 
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heart. Participants were tilted to the right to ensure a continuous column of fluid between the right 
atrium and the antecubital vein. CVP was only be measured in a subset of 5 participants in order 
to correlate JVA to a greater range of CVP than what was tested previously (Robertson & 
Amelard., Unpublished).  
Coded Hemodynamic-Imaging: CHI was set up in a manner which the jugular vein could be 
viewed within the camera’s image, as seen in Figure 16A. 
 
Figure 16: Image set up for CHI. A) The set up for CHI should yield a camera view that is 
approximately orthogonal to the right lateral neck area with unobstructed view into the clavicular 
region optimally measure jugular venous properties. B) Calibration image for the CHI. 
CHI was calibrated using a highly difuse nitrile rubber reflectance target that was  sized to the 
length of the participants neck, as seen in Figure 16B. 30-second video imaging by CHI took place 
every 5 minutes once the partcipant has been placed in a supine postion (1 supine baseline video, 
4 videos in 12° HDT, 4 videos in 30° HDT and 4 supine recovery videos).   
Cerebrovascular Monitoring: TCD (WAKIe, Atys Medical., Soucieu-en-Jarrest, France), was 
utilized to continuously measure CBV within the middle cerebral artery (MCA). The TCD probe 
was placed in the temporal acoustic window and adjusted until optimal signal was acquired. The 
TCD probe was adjusted as needed throughout the protocol if the signal deteriorated.  
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Respiratory Monitoring: A nasal cannula was placed in the participants nostrils and attached to a 
carbon dioxide (CO2) sensor (Model R-1, Carbon Dioxide Sensor, Applied Electrochemistry Inc., 
Moffett Field, CA, USA) and analyzer (CD-3A, Amtek, Applied Electrochemistry Inc., Moffett 
Field, CA, USA) to continuously monitor expired CO2 levels. 
Ultrasound: 
Vascular: Vascular ultrasound was conducted using the Phillips clinical ultrasound device (iE33 
xMatrix, Koninklijke Philips N.V., Amsterdam, The Netherlands). Left IJV CSA and venous pulse 
wave velocity was assed using a 10-17 MHz linear array transducer (L9-3, Koninklijke Philips 
N.V., Amsterdam, The Netherlands). Imaging of the IJV CSA occurred every 5 minutes once the 
partcipant was in a supine postion (1 supine baseline video, 4 videos in 12° HDT, 4 videos in 30° 
HDT and 4 supine recovery videos). IJV blood velocity was also recorded at 5 minutes and 20 
minutes within each HDT condition. 
Ophthalmic: Ophthalmic ultrasound was conducted using a portable ultrasound scanner (Orcheo 
Lite, Sonoscanner, Paris, France) and a 17 MHz linear array probe. A pre-set ophthalmic setting 
on the portable ultrasound was used to assess ONSD. Participants were instructed to keep their 
gaze still and “straight ahead” with their eyes closed during the scan. Ultrasound gel was placed 
on top of the closed eye. The sonographer used the bridge of the participants nose in order to steady 
the probe while it was placed lightly on top of the closed eye. The participant was instructed to let 
the sonographer know if the pressure on the either the eye or the nose became uncomfortable. After 
the scan was complete, the sonographer used a soft tissue to wipe away the gel from the closed 
eye and then indicated to the participant that they could open their eyes.  Ophthalmic imaging 
occurred every 5 minutes once the partcipant had been placed in a supine postion (1 supine baseline 
video, 4 videos in 12° HDT, 4 videos in 30° HDT and 4 supine recovery videos). 
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Ophthalmic Tonometry: IOP was measured using the Applanation Tono-Pen Avia (Reichert 
Technologies., Depew, NY, USA). Prior to each tonometry measurement, Alcaine (Proparacaine 
Hydrochloride) topical anesthetic was applied to the eye. The topical anesthetic could only be 
applied a maximum of 3x in a single day with each application lasting approximately 15 minutes. 
Due to this limitation, IOP was only measured once after 5 minutes of sitting upright, once after 
20 minutes in 12° HDT and once after 20 minutes in 30° HDT. The IOP data were measured and 
analyzed by Yara Mohair (MSc. Candidate in Vision Sciences) and thus will not be reported within 
this thesis.  
4.4 Data Analysis 
Internal Jugular Vein Cross-Sectional Area: 
VLC video player (Version 3.0.8, VideoLAN organization) was used to extract every second frame 
of the 5-beat ultrasound cine taken of the IJV CSA, which includes the ECG trace at the top of the 
image. From the extracted frames, all frames that occurred right after the R-wave of the ECG were 
separated and analyzed. In order to determine IJV CSA from the extracted frame, these individual 
frames were uploaded into ImageJ (Image Processing and Analysis in Java, National Institutes of 
Health (NIH)) (See Figure 17). The wand (tracing) tool was used to create an outline of the IJV 
CSA, which was then measured. The outputs of the measurement are: Area, Perimeter, Major, 





Figure 17: The wand (tracing) tool in ImageJ results in the yellow outline around the outer area 
of the IJV CSA. The IJV CSA is identified by the analyzer then selected by clicking into the 
center of the area. The area inside of the yellow outline is then calculated by ImageJ. Note: the 
ECG trace at the top. Only the images occurring directly after the R-wave were analyzed.  
Internal Jugular Vein Blood Velocity: 
IJV blood velocity was measured using the MAUI software tool (Measurements from 
Arterial Ultrasound Imaging, Hedgehog Medical, Waterloo, ON). IJV blood velocity was extracted 
from ultrasound cine’s 10-beats in length and the weighted mean was averaged for every timepoint 
within an HDT condition as well as for each HDT condition overall. 
Optic Nerve Sheath Diameter: 
ONSD was measured by placing 2 sets of digital calipers approximately 3 mm and then 
4 mm behind the optic globe. The first set of calipers was placed so that they extended to the outer 
edges of the ONS as defined by the solid grey edges (Figure 18). The ONSD at 3 mm was utilized 
for statistical analysis. The second set of calipers was placed on the width of the optic nerve, so 
that the ends of the calipers reached the inner edges of the ONS, which was identified by the inner 




Figure 18: Caliper placement for measuring ONSD. Calipers A and B are placed 3 mm behind 
the globe and calipers C and D are placed 4 mm behind the globe. B and C provide ONSD 
measurements whereas A and D provide ON diameter measurements. Credit: Dr. Philippe 
Arbeille. 
Non-invasive Intracranial Pressure – Transcranial Doppler: 
In order to measure nICP-TCD, the Heldt method (Kashif et al., 2014) of calculated nICP-
TCD was utilized. This method averages nICP over a certain estimation window, in this case 30 
heart beats, utilizing continuous ABP and CBV measurements. The equation used to estimate ICP 
(nICP) is: 
𝐼?̂?𝑃 = pa(t)̅̅ ̅̅ ̅̅ ̅ − R̂q̂1(t)̅̅ ̅̅ ̅̅ ̅ 
Equation 2: The Heldt equation for estimating ICP (nICP) from continuous ABP and CBFV 
(Kashif et al. 2014) 
where pa(t)̅̅ ̅̅ ̅̅ ̅ is average MAPMCA over the 30-beat estimation window, R̂ is the estimated resistance 
of the cerebral vasculature supplied by the MCA, which is estimated by dividing MAPMCA by 
CBV, and q̂1(t)̅̅ ̅̅ ̅̅ ̅ is the average CBV in the MCA over the 30-beat estimation window. In order to 
calculate MAPMCA, ABP at the level of the brachial artery was corrected to the level of the MCA 




ℎ = 𝑥 ∙ cos (𝑎) 
Equation 3: Height correction factor 
where ℎ is the calculated vertical distance from the brachial artery to the MCA, 𝑥 is the measured 
distance from the brachial blood pressure cuff to the temporal acoustic window, and 𝑎 is 90°- HDT 
angle. 
Coded-Hemodynamic Imaging: 
30-second CHI videos were processed to generate mean JVA over the acquisition window. 
Using the computed venous pulsatility overlay on the neck, the calibrated JVA from a 1 cm length 
in the center of the jugular vein was tracked across the different HDT conditions.  
Internal Jugular Vein Blood Flow: 
IJV blood flow (mL/min) for each timepoint was calculated utilizing mean IJV CSA (cm2), 
mean IJV blood velocity (cm/s), and the conversion factor of 60 (s/min) using the following 
equation: 
𝐼𝐽𝑉 𝐵𝑙𝑜𝑜𝑑 𝐹𝑙𝑜𝑤 = 𝐼𝐽𝑉 𝐶𝑆𝐴 ∙ 𝐼𝐽𝑉 𝑀𝑒𝑎𝑛 𝐵𝑙𝑜𝑜𝑑 𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦 ∙ 60 
Equation 4: Calculation of IJV blood flow. 
4.5 Statistical Analysis  
General Statistics: 
The IJV CSA, CVP, ONSD, and nICP-TCD were calculated overall for each HDT angle 
(baseline, 12°, 30°, and recovery). For all analyses, statistical significance will be set a priori at 
α=0.05. All statistical analysis was completed in R-Studio (R: A language and environment for 




Objective #1 took two approaches, a repeated measures correlation and individual 
regressions, to explore the ability of JVA to reflect changes in independent estimators of ICP taken 
from mean ONSD and nICP-TCD during HDT. 
Repeated measures correlations using the rmcorr statistical package (Bakdash & 
Marusich., 2020) were completed to determine associations between JVA and nICP-TCD as well 
as JVA and ONSD.  
Individual regression slopes and correlation were calculated for each participant due to 
individual differences in vessel depth, adiposity and skin tone, which impact the slope of change 
for JVA. All individual correlations were then used to calculate rmean and rmedian as well as the 1
st 
and 3rd interquartile range (IQR). 
Objective #2:  
Linear mixed models were generated using the lme4 statistical package (Bates et al., 2015) 
to determine main effects of HDT and time on IJV blood flow, IJV CSA, ONSD and nICP-TCD. 
The estimated marginal means as well as Tukey post-hoc analysis were calculated with the 
emmeans statistical package (Lenth, 2020) to determine how IJV blood flow and IJV CSA changed 
over time (5-minutes, 10-minutes, 15-minutes, 20-minutes) and with condition (baseline, 12°, 30°, 
recovery). Repeated measures correlations were also performed to assess associations between IJV 
blood flow, nICP-TCD and ONSD as well as between IJV CSA, nICP-TCD and ONSD.  
5.0 RESULTS 
5.1 Participant Characteristics 





Table 6: Participant demographic information. Physiological information was taken during 
baseline. Where SBP=systolic blood pressure, DBP=diastolic blood pressure, HR=heart rate, 
BMI=body mass index.  
Outcome Mean ± SD 
n (F) 11 (5) 
Age (years) 26±6 
Height (cm) 166±10 
Weight (kg) 64±11 
SBP (mmHg) 117±9 
DBP (mmHg) 73±6 
MAP (mmHg) 90±5 
HR (bpm) 60±9 
BMI (kg/m2) 23±2 
 
All physiological averages and standard deviations across all HDT conditions for all participants 
are reported in Table 7. HR, MAP, SV, CVP, CBV, IJV blood flow and ONSD did not change 
significantly during 12° HDT, 30° HDT or recovery compared to baseline, although HR and MAP 
both significantly increased from 12° HDT to 30° HDT. ONSD significantly decreased between 
12° HDT and recovery as well as 30° HDT and recovery. Both MAPMCA and nICP-TCD 
significantly increased from baseline to 30° HDT, with no increase between baseline and 12° HDT.  
IJV blood velocity decreased significantly from baseline to 12° HDT as well as from baseline to 
30° HDT. IJV CSA and JVA significantly increased at 12° HDT and 30° HDT compared to 
baseline, and also significantly increased between 12° HDT and 30° HDT. One participant ceased 
testing after completing 12° HDT, therefore 30° HDT and recovery conditions are only n=10. In 
addition, CBV data were not acquired for one participant due to technical difficulties, and therefore 
all measures utilizing CBV and nICP-TCD have an n=10. One participant was removed from the 
ONSD analysis due to imaging difficulty. 
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Table 7: Mean±standard deviation for physiological variables during all HDT conditions. n=11 
unless otherwise indicted. 
Measure Baseline 12° 30° Recovery 
HR (bpm) 60±9 60±11 62±7# 62±7 
MAP (mmHg) 90±5 88±8 95±8# 95±5 
SV (mL) 71±15 70±14 71±15 72±15 
CVP (mmHg) [n=4] 10.5±2.9 11.2±1.4 10.5±2.4 8.5±1.6 
CBV (cm/s) [n=10] 60±13 59±12 59±12 61±13 
MAPMCA (mmHg) 90±5 94±8 108±7** 95±5 
nICP-TCD (mmHg) 
[n=10] 
18±13 19±12 31±10** 19±12 
IJV Area (cm2) 0.76±0.30 1.22±0.45* 1.6±0.78**# 0.87±0.31 
IJV Blood Velocity (cm/s) 13.4±6.4 8.5±3.1* 7.5±3.9** 13.8±7.9 
IJV Blood Flow (mL/min) 596±328 588±293 637±236 704±321 
ONSD (mm) [n=10] 5.6±1.0 5.8±0.5 5.7±0.8 5.2±0.8 
JVA (a.u.) 0.64±0.09 0.71±0.12** 0.73±0.15**# 0.62±0.09 
 *p<0.05, **p<0.001, indicates changes from baseline. #p<0.05, indicates changes between 12° 























5.2 Associations between JVA, IJV CSA and CVP 
JVA had a moderate, positive association with IJV CSA (rrm=0.51, p<0.001) (Figure 19).  
 
Figure 19: Repeated measured correlation between JVA and IJV CSA at each timepoint within 
each HDT condition, for a total of 13 data points per participant. Each individual participant is 
represented by a different colour. 
Individual correlations between JVA and IJV CSA also suggest a moderate to strong association 




Figure 20: Individual correlations between JVA and IJV CSA at each timepoint within each 
HDT condition, for a total of 13 data points per participant. Each individual participant is 
represented by a different colour. Data are presented as rmedian(1
st, 3rdIQR). 
After the removal of one outlier due to being more than 1.5±IQR from the mean, leaving 




Figure 21: Repeated measured correlation between JVA and CVP at each timepoint within each 
HDT condition, for a total of 13 data points per participant. Each individual participant is 
represented by a different colour. 
The average of individual correlations between mean CVP (mmHg) and JVA also suggests only a 





Figure 22: Individual correlations between JVA and CVP at each timepoint within each HDT 
condition, for a total of 13 data points per participant. Each individual participant is represented 
by a different colour. Data are presented as rmedian(1
st, 3rdIQR). 
5.3 Associations between JVA, nICP-TCD and ONSD 
JVA and nICP-TCD were significantly but weakly correlated (rrm=0.28, p=0.003). The 




Figure 23: Repeated measured correlation between JVA and nICP-TCD at each timepoint within 
each HDT condition, for a total of 13 data points per participant. Each individual participant is 
represented by a different colour. 
In addition, JVA and ONSD were poorly and non-significantly correlated (rrm=0.17, 
p=0.078), suggesting that there is no association between JVA and ONSD. The association 




Figure 24: Repeated measured correlation between JVA and ONSD at each timepoint within 
each HDT condition, for a total of 13 data points per participant. Each individual participant is 
represented by a different colour. 
Due to individual differences in vessel depth, IJV compliance, adiposity, and skin tone, the 
slope of change for JVA in respect to changes in hemoglobin is different for every individual. To 
account for these individual differences during our comparisons, we calculated individual 
correlations between JVA, nICP-TCD, and ONSD for each participant. JVA and nICP-TCD were 
positively but weakly correlated on an individual level (rmean=0.24, rmedian=0.31). Individual 









Table 8: Individual intercepts, slopes, r2, and r values for each participant between JVA and 
nICP-TCD. 
ID Intercept Slope r2 r 
FOP01 0.532 -0.000821 0.07 -0.27 
FOP02 0.553 0.0026439 0.15 0.39 
FOP03 0.653 0.0052543 0.44 0.67 
FOP04 0.553 0.0017293 0.10 0.31 
FOP07 0.709 0.0010399 0.01 0.08 
FOP08 0.564 0.0010452 0.47 0.68 
FOP10 0.703 0.0026979 0.23 0.48 
FOP13 0.615 0.0056595 0.09 0.30 
FOP15 0.788 -0.001388 0.08 -0.28 
FOP16 0.774 0.0011762 0.01 0.07 
 
 
Figure 25: Individual correlations between JVA and nICP-TCD at each timepoint within each 
HDT condition, for a total of 13 data points per participant. Each individual participant is 




JVA and ONSD are poorly correlated on an individual level (rmean=0.09, rmedian=0.17), 
suggesting that there is only a weak association between JVA and ONSD. Individual correlations 
between JVA and ONSD are shown in Table 9 and visually represented in Figure 26. 
Table 9: Individual intercepts, slopes, r2, and r values for each participant between JVA and 
ONSD. 
ID Intercept Slope r2 r 
FOP01 0.520 -0.00148 0.00 -0.04 
FOP02 0.730 -0.02335 0.08 -0.28 
FOP03 0.251 0.080793 0.31 0.56 
FOP04 0.373 0.033258 0.28 0.53 
FOP06 0.689 -0.01318 0.02 -0.13 
FOP07 0.630 0.016015 0.04 0.20 
FOP08 0.713 -0.02076 0.26 -0.50 
FOP10 0.783 -0.00791 0.01 -0.11 
FOP13 0.457 0.060458 0.33 0.58 
FOP15 0.712 0.007239 0.04 0.20 





Figure 26: Individual correlations between JVA and ONSD at each timepoint within each HDT 
condition, for a total of 13 data points per participant. Each individual participant is represented 
by a different colour. Data are presented as rmedian(1
st, 3rdIQR). 
5.4 Changes in IJV blood flow, IJV CSA, ONSD, and nICP-TCD with HDT 
There was not a main effect for time for IJV blood flow, IJV CSA, ONSD, or nICP-TCD. 
The remainder of the results will focus on how these variables changed with HDT condition solely.  
IJV blood flow did not change significantly with any HDT and did not have a main effect 




Figure 27: IJV blood flow across all conditions of HDT. The boxplots represent the values within 
the 1st and 3rd IQR and the solid line represents the median value. Individual data points are 
placed overtop of the boxplots, where each ID is represented by a separate colour.  
Using the Marshall-Goebel et al., (2019) visual grading scale, some changes in flow type 












Table 10: Visual grading of IJV blood flow for all participants across three HDT conditions. This 
visual identification scale was created by Marshall-Goebel et al., (2019). Grade 1 indicates 
continuous forward flow. Grade 2 indicated pulsatile flow that returns to 0. Grade 3 indicates 
equal amounts of forward and reverse flow.  
ID Baseline 12° 30° 
FOP01 1 1 2 
FOP02 2 2 2 
FOP03 2 2 2 
FOP04 1 2 2 
FOP06 1 1 1 
FOP07 2 2 2 
FOP08 2 2 2 
FOP10 2 1 3 
FOP13 2 2 2 
FOP15 1 1 N/A 
FOP16 2 2 2 
  
Not unexpectedly, IJV CSA significantly increased from baseline to 12° (p<0.05), from 
baseline to 30° (p<0.001), and from 12° to 30° (p<0.05). There was no significant difference from 
baseline to recovery (p=0.97). A significant main effect of HDT on IJV CSA was present 




Figure 28: IJV CSA across all conditions of HDT. The boxplots represent the values within the 
1st and 3rd IQR and the solid line represents the median value. Individual data points are placed 
overtop of the boxplots, where each ID is represented by a separate colour. *p<0.05, **p<0.001. 
ONSD did not change significantly with any HDT condition compared to baseline. 
However, ONSD significantly decreased from 12° HDT to recovery (p<0.05) as well as between 









Figure 29: ONSD across all conditions of HDT. The boxplots represent the values within the 1st 
and 3rd IQR and the solid line represents the median value. Individual data points are placed 
overtop of the boxplots, where each ID is represented by a separate colour.  *p<0.05.  
nICP-TCD increased significantly from baseline to 30° HDT (p<0.001) as well as from 12° 
HDT to 30° HDT (p<0.001), as well as significantly decreased from 30° HDT to recovery. There 






Figure 30: nICP-TCD across all conditions of HDT. The boxplots represent the values within the 
1st and 3rd IQR and the solid line represents the median value. Individual data points are placed 
overtop of the boxplots, where each ID is represented by a separate colour. **p<0.001.  
5.5 Associations between IJV blood flow, ONSD, and nICP-TCD 
IJV blood flow and ONSD were not significantly correlated (rrm=0.10, p=0.485) suggesting 








Figure 31: Repeated measures correlation between IJV blood flow and ONSD at each timepoint 
within each HDT condition, for a total of 13 data points per participant. Each participant is 
represented by a separate colour. 
In addition, IJV blood flow was also not significantly correlated with nICP-TCD 
(rrm=-0.09, p=0.495) suggesting no association between IJV blood flow and nICP-TCD. This 




Figure 32: Repeated measures correlation between IJV blood flow and nICP-TCD at each 
timepoint within each HDT condition, for a total of 13 data points per participant. Each 

















5.6 Associations between IJV CSA, ONSD, and nICP-TCD 
IJV CSA and ONSD were not significantly correlated (rrm=0.14, p=0.137) (Figure 33). 
 
Figure 33: Repeated measures correlation between IJV CSA and ONSD at each timepoint within 
each HDT condition, for a total of 13 data points per participant. Each participant is represented 
by a separate colour 
IJV CSA and nICP-TCD had a significant but weak positive correlation (rrm=0.19, p<0.05) 
suggesting a possibility of an association between IJV CSA and nICP-TCD. The association 




Figure 34: Repeated measures correlation between IJV CSA and nICP-TCD at each timepoint 
within each HDT condition, for a total of 13 data points per participant. Each participant is 
represented by a separate colour 
6.0 DISCUSSION: 
This study aimed to demonstrate the ability of the novel, non-contact CHI imaging device 
to detect changes in ICP as predicted by two methods of nICP (ONSD and nICP-TCD). It was 
hypothesized that JVA, measured by CHI, would reliably detect changes in nICP, the current study 
does not support this hypothesis. The study also measured the effects of severe HDT on IJV CSA 
and IJV blood flow and how these outcomes in turn affect nICP. While this study supported the 
hypothesis that extreme HDT would result in an increase in IJV CSA, it failed to support the 
hypothesis that extreme HDT would attenuate IJV blood flow. It also did not support the 
hypothesis that strong associations would exist between IJV CSA, IJV blood flow, nICP-TCD and 
ONSD.   
6.1 Associations between JVA, IJV CSA and CVP 
Fundamentally, CHI detects changes in hemoglobin content in the superficial vasculature 
by shining an infrared light source over the area of interest, then calculating the changes in 
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attenuation, based on the absorption of light (Amelard et al., 2016, 2017, 2015). The more 
hemoglobin that is present in the area of interest, the greater the attenuation will be. Since 
hemoglobin is contained within red blood cells, CHI theoretically provides information about 
blood volume in the vessel of interest. By leveraging the pressure-volume relationship, pulsatile 
waveforms can also be extracted from a 30s CHI video (Amelard et al., 2017). In the context of 
this study, we aimed to extract the attenuation of the internal jugular vein (JVA) which 
theoretically would provide information on IJV volume and JVP as a surrogate of CVP.  
The ability of JVA to track changes in IJV CSA was similar in this study (rrm=0.51, 
p<0.001; rmean=0.57, rmedian=0.78) compared to a recent study which utilized 5.4° HDT (as well as 
LBNP) (rrm=0.61, p<0.001; rmean=0.65, rmedian=0.84) (Robertson & Amelard., Unpublished) 
suggesting JVA and IJV CSA are moderately associated. However, the slightly lower association 
observed between JVA and IJV CSA in this study may be a result of the more severe HDT inducing 
a greater cephalad fluid shift. This could be indicative of the idea that there is possibly an upper 
limit of IJV pressure-volume curve, or of vessel volume that CHI can reliably measure. However, 
CHI is unable to clearly define vessel walls, which may result in the JVA not being calculated 
using the entire vessel, which could also be why differences exist between JVA and IJV CSA. 
Differences between JVA and IJV CSA may also stem from the limitations of ultrasound. 
Measuring IJV CSA using ultrasound assumes that the IJV CSA is uniform along the entire vessel, 
which is inaccurate as the vessel shape changes along its length (Saiki, Tsurumoto, Okamoto, & 
Wakebe, 2013). If the IJV CSA and JVA were calculated on slightly different areas along the IJV, 
it is possible that those two areas would have a different IJV CSA, resulting in poorer correlation 
between the two measures. In this study, we also calculate JVA from the right side of the neck, 
and IJV CSA from the left side of the neck, meaning we are assuming them to have the same IJV 
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CSA, which is not an accurate assumption, as bilateral differences in IJV CSA have been recorded 
previously in human cadaver specimens (Saiki et al., 2013). The IJV CSA was also calculated 
using five cardiac cycles, and only measured after the R-wave of the electrocardiogram which 
corresponds with the c wave of the JVP, where as JVA was calculated and averaged across approx. 
30 total cardiac cycles, which may contribute to the discrepancy seen. Lastly, CHI, in theory, is a 
derivation of blood volume (hemoglobin content) compared to just a single IJV CSA (transverse 
slice of the IJV), which could account for the discrepancies between the two measurements. 
Overall, JVA has a promising moderate association to IJV CSA that suggests that CHI does have 
the ability to detect changes in IJV blood volume. 
 Interestingly, in this study, JVA and mean CVP had a moderate relationship (rrm=0.48, 
p<0.001; rmean=0.45, rmedian=0.67) which differs from the results of the previous study which 
utilized 5.4° HDT as well as LBNP (rrm=0.61, p<0.001; rmean=0.64, rmedian=0.89) (Robertson & 
Amelard., Unpublished). The current study only had 4 participants (out of 5) that had a functioning 
CVP trace, severely limiting the ability to derive any conclusions from the data. Differences in 
methodologies between the two studies (12° and 30° HDT vs. 2.7° and 5.4° HDT) may impact the 
differences in the results and could suggest that CHI’s ability to track changes in CVP may 
diminish as an increased cephalad fluid shift occurs. More research is needed to determine how 
severe cephalad fluid shifts may impact the ability of JVA, measured by CHI, to track changes in 
CVP, as the current data does not provide enough information to support or refute this capability.  
6.2 Limited association between JVA, nICP-TCD and ONSD 
Due to the risk of invasive ICP monitoring, finding a non-invasive alternative to measure 
ICP has become essential in order to track ICP changes in extreme remote environments such as 
the ISS, as well as to facilitate ICP research in healthy populations. While current methods such 
as ONSD and nICP-TCD have promising results (Kashif et al., 2014; Tayal et al., 2007), these 
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methods still require contact with the skin and a trained operator. The current study investigated 
the ability of the non-contact, camera-based CHI imaging device to detect changes in ICP by 
comparing the changes in JVA with two nICP methods (ONSD and nICP-TCD). The initial 
hypothesis was based on the CHI’s ability to detect changes in IJV CSA and CVP during a variety 
of HDT and LBNP conditions (Robertson & Amelard., Unpublished) as well as the CHI’s ability 
to detect the JVP (Amelard et al., 2017). Previous research has established a strong relationship 
between changes in CVP and changes in both ICP and nICP (Czosnyka et al., 1999; Eklund et al., 
2016; Hamilton et al., 2011; Lawley et al., 2017; Petersen et al., 2016; Qvarlander, Sundstrom, 
Malm, & Eklund, 2013). Increases in IJV CSA are also linked with increases in ICP (Davies et al., 
1996; Stone et al., 2010) thus by being able to track changes in CVP and IJV CSA with CHI-
derived-JVA, we should also be able to track changes in ICP. However, the weak positive 
association between JVA and nICP-TCD (rrm=0.28, p=0.003) suggests that CHI may not reflect 
the same information as changes in nICP. Even when utilizing individual regressions to account 
for between person differences due to vessel-depth, IJV compliance, adiposity and skin colour, 
which can affect the JVA on an individual level due to differences in absorption, JVA and nICP-
TCD were weakly correlated (rmean=0.24, rmedian=0.31), again suggesting that CHI may not indicate 
the same information as changes in nICP. It is important to consider that these conclusions are 
based on an nICP method, and the only way to truly test if CHI is able to track changes in ICP and 
therefore be a suitable ICP surrogate would be to compare JVA to invasive measures of ICP. 
Limitations of both nICP-TCD and CHI, which may contribute to the weak association observed 
within this study are discussed in detail below in section 6.3 and 7.0. 
While this study and previous studies have shown a moderate association between JVA 
and IJV CSA, CHI’s ability to detect changes in IJV CSA may not be beneficial in tracking changes 
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in nICP. Lawley et al., (2017) found that during acute bouts of microgravity, ICP decreased despite 
a significant increase in IJV CSA. This suggests that while IJV CSA can indicate venous 
congestion which may impact ICP (Marshall-Goebel et al., 2016; Stone et al., 2010), an increase 
in IJV CSA does not always confirm an increase in ICP, especially while in microgravity (Lawley 
et al., 2017).  
It has long been suggested that CVP has the strongest influence on ICP compared to other 
venous and arterial factors (Davies et al., 1996; Davson, Domer, & Holungsworth, 1973; Eklund 
et al., 2016; Kramer et al., 2017; Petersen et al., 2016; Ursino & Lodi, 2017; Wilson, 2016) Due 
to this, the ability to non-invasively detect CVP through CHI-derived-JVA confidently may be the 
key to unlocking the capability to detect changes in ICP with no contact. Although the current 
study does not have enough CVP data to make any conclusions on the association between JVA 
and CVP, previous studies have instilled confidence that CHI is able to reliably detect changes in 
CVP while supine, and while in 2.7° HDT and 5.4° HDT (Amelard et al., 2017, Amelard et al., 
Unpublished). Further research is needed to investigate if there is an upper limit of detectability 
for JVA with cephalad fluid shift which may impact the ability of the CHI to reliably track these 
changes in CVP and therefore may impact the ability of CHI to act as an nICP surrogate.  
While JVA was weakly but significantly associated with nICP-TCD, no association 
appears to exist between JVA and ONSD (rrm=0.17, p=0.08; rmean=0.09, rmedian=0.17). However, in 
this study the ONSD did not change as expected, which may have impacted the association 
between JVA and ONSD, resulting in a weaker association. The limitations of the ONSD 
measurement are discussed below in detail in section 6.3.   
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6.3 Severe HDT results in changes in IJV CSA and nICP-TCD but not IJV blood flow or 
ONSD 
Previous studies have examined the effect of various degrees of HDT on IJV CSA, IJV 
blood flow, ONSD, and ICP or nICP, but rarely have these studies assessed all four of these 
variables simultaneously or at 30° HDT. By assessing these four variables simultaneously, we may 
be better able to give insight into how cerebral venous outflow impacts nICP, as well as assessing 
them at 30° HDT, which has been suggested to cause the amount of cephalad fluid shift most 
similar to that observed in in microgravity (Sirek et al., 2014).  
IJV CSA 
IJV CSA progressively increased at both 12° HDT (p<0.05) and 30° HDT (p<0.001) 
compared to baseline. This was expected as multiple studies have found that IJV CSA increases 
significantly at 6°, 12°, 18°, 24°, and 30° HDT when compared to supine values (Arbeille et al., 
2001; Clenaghan et al., 2005; Ishida et al., 2018; Marshall-Goebel et al., 2016, 2018). Our study 
also confirms that in severe HDT (12° and 30°)  IJV CSA does not significantly change over a 20-
minute time period after the initial significant increase, which has only previously been confirmed 
in 10° HDT (Schreiber et al., 2002). This suggests that IJV CSA reaches a plateau quickly and 
remains elevated. IJV CSA and IJV volume have been shown to stay increased relative to baseline 
values for up to 42 days in HDT and up to 6-months in spaceflight (Arbeille et al., 2001), increasing 
confidence that results from this study are relatable to what we might see during spaceflight. 
nICP-TCD 
nICP-TCD was significantly increased at 30° HDT compared to baseline and 12° HDT 
(p<0.001). While nICP-TCD methods have not previously been utilized with 30° HDT, invasive 
ICP measurements at 30° HDT provide support that a significant increase in nICP-TCD would be 
expected (Lee, 1989). Our finding of no significant increase of nICP-TCD at 12° HDT is both 
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supported and not-supported by the current literature, making it clear that more research needs to 
be done in order to validate nICP-TCD methods during HDT. When using invasive ICP 
measurements, significant changes in ICP have been found at as little as 9° HDT (Eklund et al., 
2016; Petersen et al., 2015, 2018), however, when utilizing various nICP-TCD methods, no 
significant changes in nICP have been found at 12°, 18°, or 20° HDT (Marshall-Goebel et al., 
2017; Robba et al., 2016). Invasive ICP data can only be gained from patients that are already 
undergoing ICP monitoring for another health condition. Therefore, there is no evidence on how 
ICP truly changes in a completely healthy person during HDT, making it possible that nICP 
evidence suggesting that ICP is not significantly increased at 12° HDT in healthy participants is 
accurate. ICP regulation during postural transitions has been proposed to be better in relatively 
‘healthy’ patients undergoing ICP monitoring post-tumor removal compared to those patients 
undergoing ICP monitoring for other reasons (Andresen et al., 2014) suggesting that in completely 
healthy participants, ICP regulation may be so strong that a nICP increase at 12° HDT may not 
occur. The method of nICP-TCD that was utilized in this study relies on estimating ICP from 
changes in CBV and MAPMCA (Kashif et al., 2014). The significant increase in nICP-TCD at 30° 
HDT is clearly driven by the significant increase in MAPMCA (p<0.001) that also occurred at 30° 
HDT as CBV does not significantly change in any condition. At 12° HDT, MAPMCA is not 
significantly increased from baseline, which is contributing to the lack of significant increase in 
nICP-TCD.  ICP and MAP are both important contributors to CPP (CPP=MAP-ICP) where 
increased ICP can lead to a decrease in CPP (Armstead, 2016). Cerebral autoregulation helps to 
maintain ICP in healthy adults in order to protect CPP, where increases in pressure results in 
vasoconstriction of the cerebral vasculature in order to reduce cerebral blood volume and therefore 
maintain ICP (Armstead, 2016). It is possible that in a healthy adult, at 12° HDT, cerebral 
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autoregulation may have the ability to counteract the initial increase in cerebral blood volume 
which could result in the maintenance of ICP. However, due to there being no invasive ICP studies 
in the healthy population, there is no way to know exactly how ICP changes in 12° HDT within 
that population, leading to ambiguity when attempting to interpret the nICP-TCD data. 
Limitations also exist when comparing results that are from different methods of nICP-
TCD. Not all nICP methods show a strong correlation to invasively measured ICP and none have 
undergone rigorous validation against invasively measured ICP (Cardim et al., 2016) and therefore 
using different nICP-TCD methods may produce varying results. While our study chose to utilize 
an nICP-TCD method with strong initial evidence (Cardim et al., 2016), to our knowledge, this is 
the first study to utilize the Heldt method of nICP-TCD (Kashif et al., 2014) outside of a clinical 
setting, and the first to utilize the method during any level of HDT. Therefore, an unknown 
limitation of applying the method during HDT may be present. The Heldt method does not account 
for any changes that may occur in CVP, instead only taking into account MAPMCA and CBV. 
Evidence suggests that postural changes in ICP are rarely due to changes in the arterial system and 
are instead driven by changes in the venous system (Czosnyka & Pickard, 2004; Czosnyka et al., 
1999; Davies et al., 1996; Petersen et al., 2015; Petersen et al., 2018; Qvarlander, Sundström, 
Malm, & Eklund, 2013; Ursino & Lodi, 2017; Wilson, 2016) meaning that by not accounting for 
CVP, current methods of nICP-TCD, including the Heldt method, may be inaccurate when 
attempting to quantify ICP during HDT. Like ICP, CVP can currently only be measured using 
invasive techniques, making it impossible currently to utilize CVP in any nICP-TCD method. 
Kashif et al., (2016) reported a bias of 1.6 mmHg and a standard deviation of error of 7.6 mmHg 
compared to invasively measured ICP when using the Heldt nICP-TCD method, as well as a low 
sensitivity (83%) and specificity (70%) for the detection of elevated ICP. This error is sometimes 
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evident within this study, for instance, FOP02 records a baseline nICP-TCD of -4.7 mmHg, which 
is highly unlikely in a supine position. Recently, the Heldt method (Kashif et al., 2016) was 
improved upon by including a simple model of cerebral hemodynamics as well as including a 
pseudo-Bayesian filter, which reduced the bias to 0.6 mmHg and reduced the root-mean-squared 
error to 3.6 mmHg (Imaduddin, Fanelli, Vonberg, Tasker, & Heldt, 2019). During this study we 
did not have time to implement this new addition to the Heldt method of nICP-TCD, however, 
continuing forward we plan to implement this updated calculation, which may lead to more 
confident results. Error in our study’s measurement may also have been introduced due to the use 
of continuous mean finger arterial blood pressure recalculated to the level of the brachial artery, a 
method which may systematically overestimate blood pressure, that was then manually 
recalculated to the level of the mid-brain, therefore possibly overestimating MAPMCA. Overall, 
based on previous evidence we can be confident that ICP as estimated by nICP-TCD is truly 
increasing at 30° HDT. More information is needed to validate nICP-TCD methods, which may 
help fill the gap in knowledge about how ICP changes at 12° HDT in completely healthy adults. 
ONSD 
ONSD did not significantly change with any HDT condition compared to baseline, a 
finding that is not aligned with previous literature. ONSD did significantly decrease from 12° HDT 
to recovery (p<0.05) and from 30° HDT to recovery (p<0.05) suggesting that although ONSD did 
not significantly increase during HDT, ONSD did decrease upon the return to supine which was 
expected.  Multiple studies have suggested that an ONSD>5-5.5 mm is an indication of 
ICP>15 mmHg (Amini et al., 2013; Chin et al., 2015; Kimberly et al., 2008; Rajajee, Fletcher, 
Rochlen, & Jacobs, 2012; Tayal et al., 2007), and therefore ONSD>5-5.5 mm would be an 
indication of elevated ICP. In our study, ONSD at baseline was 5.6±1.0 mm, which is objectively 
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higher compared to the ONSD (~4.5 mm) in those patients with a normal ICP in a supine position 
(Amini et al., 2013; Chin et al., 2015; Kimberly et al., 2008; Robba et al., 2016; Tayal et al., 2007). 
The elevated ONSD in baseline may be a reason we see no significant changes in ONSD during 
12° HDT or 30° HDT as ONSD is often found to increase significantly after 12° HDT (Chin et al., 
2015; Marshall-Goebel et al., 2017b; Robba et al., 2016; Sirek et al., 2014), which is contradictory 
to our findings.  
 Elevated (ONSD>5-5.5 mm) seated and supine ONSD in healthy participants have been 
reported in the literature previously (Kishk et al., 2018; Laurie et al., 2017; Sirek et al., 2014) 
leading to questions about variability within ONSD measurements. The intra-rater variability for 
ONSD was calculated to be 0.69, or moderate, for these results. Defining the ONSD on ultrasound 
images can be subjective, and has previously resulted in one sonographer consistently measuring 
a greater ONSD than a second sonographer using the same ultrasound images (Hamilton et al., 
2011). Therefore, differences in supine ONSD values across studies may arise from individual 
subjective differences in defining the ONSD on ultrasound images. Another limitation of ONSD 
that is often cited within the literature is that ONSD does not directly translate into an ICP or nICP 
measurement in mmHg, instead only acting as an indication of elevated ICP (Kimberly et al., 
2008b; Tayal et al., 2007). For example, an ONSD of 6.0 mm does not directly indicate any ICP, 
but instead only indicates that ICP>15 mmHg, after which invasive monitoring would still be 
required to determine true ICP as well as to track any further increase in ICP. Due to this, research 
has recently focused on finding methods of tracking ICP that can give an indication of changes in 
mmHg, such as nICP-TCD. ONSD cannot track second-by-second changes in ICP, making it 
difficult to track changes in ICP over time. nICP methods such as nICP-TCD and CHI could make 
continuous, non-invasive ICP monitoring a reality. Other limitations of ONSD measurements are 
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related to the use of the ultrasound itself. Changing the gain between images or even between 
participants can result in a blurring of noise, making the hues of the ultrasound image more alike 
than different, and making it harder to identify optic structures. This may artificially increase or 
decrease the ONSD (De Bernardo, Vitello, & Rosa, 2020).  This possibility was limited within the 
study by keeping the gain consistent between all participants (all images), meaning any error 
within the ONSD measurement due to gain should be consistent across all measurements. Lastly, 
our study employed the use of topical anesthetic on the eye in order to comfortably take IOP 
measurements for a separate analysis unrelated to our primary outcome. While the effect of topical 
anesthetic on ONSD has not been studied, certain inhaled and epidural anesthetics have been found 
to increase ONSD (Hong, Jung, & Park, 2019;  Lee et al., 2017; Tire, Çöven, Cebeci, Yilmaz, & 
Başaran, 2019), although with epidural anesthetic this increase in ONSD may be due to increased 
volume within the SAS and not due to the anesthetic itself. While we do not know if this is the 
case in our study, it could help to explain the higher than expected baseline ONSD values. Table 
11 identifies participants who received Proparacaine Hydrochloride in both eyes prior to the 
baseline measurements of ONSD. Due to individual differences in comfort and reactivity to the 
IOP tonometer, putting the Proparacaine Hydrochloride in both eyes was sometimes necessary, 
but unfortunately was not always consistent between HDT conditions and was not consistent in 
timing (i.e. for supine the Proparacaine Hydrochloride was applied before the ONSD 
measurement, whereas for 12° HDT and 30° HDT the Proparacaine Hydrochloride was applied 
after the ONSD measurement was completed. There was no Proparacaine Hydrochloride applied 
for recovery). Due to this, we are unable to make any conclusions regarding the effect of 
Proparacaine Hydrochloride on ONSD within our study. Conversely, it may be the tension caused 
by the insertion of the eye drop that could be contributing to the observed ONSD increase. Future 
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research should explore the effect of topical anesthetic, such as Proparacaine Hydrochloride, on 
ONSD since current research, especially within the SANS field, often measure both ONSD and 
IOP.  
Table 11: Individual ONSD values across all HDT conditions. Highlighted participants indicate 
those that received drops of Proparacaine Hydrochloride in both eyes prior to supine 
measurements. 
ID Baseline 12° 30° Recovery 
FOP01 5.06 6.15 6.62 6.00 
FOP03 5.18 5.86 5.54 4.81 
FOP04 5.58 5.99 6.22 5.37 
FOP06 6.24 6.55 6.18 5.97 
FOP07 6.08 5.31 5.58 5.67 
FOP08 5.89 6.05 5.97 5.66 
FOP10 6.69 5.04 5.49 5.21 
FOP13 6.45 5.67 5.94 4.37 
FOP15 5.33 6.31 NA NA 
FOP16 3.28 4.97 3.76 3.56 
 
IJV Blood Flow 
We found no differences in IJV blood flow between any HDT conditions, which is not 
consistent with what was previously reported within the literature. Significant changes in IJV 
blood flow have been found previously at 12° HDT both acutely (Ishida et al., 2018) and after 4.5 
hours (Marshall-Goebel et al., 2016), although the changes in IJV blood flow occurred in opposite 
directions. In addition, Marshall-Goebel et al., (2016) found that IJV blood flow remained near 
supine values after 4.5 hours in 18° HDT, which supports our data indicating an increase in IJV 
blood flow at 30° HDT. Together, these data suggest that the amount of cephalad fluid shift 
determined by degrees of HDT may impact IJV blood flow. The current study is powered based 
on the effect size for changes in IJV CSA, and had data for all 16 participants been able to be 
collected, it is possible a significant decrease in IJV blood flow at 12° HDT would have occurred 
as it did in the study conducted by Marshall-Goebel et al., (2016) or conversely a significant 
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increase in IJV blood flow would have occurred as observed by Ishida et al., (2018). Within our 
study, we found that both MAPMCA and nICP-TCD increased with HDT, theoretically maintaining 
CPP (CPP=MAPMCA-ICP), which is consistent with Petersen et al., (2015) who found no 
significant changes in CPP with 10° HDT or 20° HDT using invasive ICP measurements. If 
resistance within the cerebrovasculature also remained constant, cerebral blood flow would remain 
constant, leading to no significant changes in IJV blood flow as we witnessed. Future research 
should focus on identifying mechanisms of IJV blood flow and cerebral autoregulation during 
severe cephalad fluid shifts in order to help provide clarity to the role of cerebral venous outflow 
on ICP.  
We also visually identified IJV blood flow patterns for each participant and graded IJV 
blood flow based on the grading scale created by Marshall-Goebel et al., (2019).  We found that 
the majority of participants had grade 2 flow during baseline, 12° HDT, and 30° HDT, indicating 
that IJV blood flow was pulsatile with periods of stagnant flow. This is largely supported by 
Marshall-Goebel et al., (2019) who found largely grade 2 flow during supine and 15° HDT, 
suggesting that IJV blood flow can become briefly stagnant, but does not flow backwards into the 
cranial cavity even in extreme HDT. This differs from findings in microgravity, where grade 3 or 
4 flow has been found, indicating large periods of stagnation and reverse flow (Marshall-goebel et 
al., 2019). This suggests that mechanisms of cerebral venous outflow may be different in 
microgravity compared to HDT, and cerebral venous congestion and outflow may not be replicated 
accurately during HDT research. Additionally, while neither IJV blood flow nor flow grade 
changed with HDT, conventional ultrasound is not able to measure secondary flow patterns or 
helical flow, which is known to be associated with the development of atherosclerotic lesions and 
thrombosis (Warboys, Amini, De Luca, & Evans, 2011; Yiu, 2019) which can result in an increase 
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in ICP and have recently been found to occur while in microgravity (Duke, Ryu, Brega, & 
Coldwell, 1997; Marshall-goebel et al., 2019; Thandra, Jun, & Chuquilin, 2015). Overall, further 
research needs to be completed in order to understand how IJV blood flow changes and how 
complex flow can contribute to changes in cerebral venous outflow in both HDT and microgravity, 
as well as to understand the different mechanisms that contribute to more complex flow in 
microgravity compared to HDT.  
6.4 No relationship between IJV blood flow, ONSD, and nICP-TCD 
Cerebral venous congestion has been attributed as a cause of increased ICP (Mader et al., 
2017, 2011; Zhang & Hargens, 2017), although few studies have looked at the association of IJV 
blood flow and ICP or nICP. We found there to be no association between IJV blood flow and 
nICP-TCD (rrm=-0.09, p=0.14) or IJV blood flow and ONSD (rrm=0.05, p=0.69). We hypothesized 
that a negative relationship would exist between IJV blood flow and nICP-TCD, as we expected a 
decrease in IJV blood flow to be an indication of cerebral venous congestion, and therefore 
correspond to an increase in nICP-TCD and/or ONSD. However, while we did see a non-
significant decrease in IJV blood flow in 12° HDT, IJV blood flow increased at 30° HDT, adding 
to the complexity of defining IJV blood flow’s role in cerebral venous congestion. To our 
knowledge, this is the first study that has attempted to define the relationship between IJV blood 
flow during a cephalad fluid shift, cerebral venous congestion, and its effect on nICP.  A possible 
limitation in determining how cerebral venous outflow impacts nICP within our study is that we 
did not account for vertebral vein outflow, which is the second main pathway of cerebral venous 
outflow (Gisolf et al., 2004). However, previous research has indicated that vertebral vein outflow 
does not significantly change with HDT (Ciuti et al., 2013; Ogoh et al., 2015), allowing us to be 
confident that changes in cerebral venous outflow that could impact ICP or nICP would be due to 
changes in IJV blood flow. Overall, complexity of IJV blood flow and the kinetic energy loss 
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associated with high resistance or turbulence may be a better indicator of cerebral venous 
congestion and therefore could impact ICP and nICP to a greater extent than IJV blood flow 
quantity itself (Duke et al., 1997; Marshall-goebel et al., 2019; Thandra et al., 2015). 
6.5 Limited associations between IJV CSA, ONSD, and nICP-TCD 
Increases in ICP have previously been attributed to increased IJV CSA (Davies et al., 1996; 
Stone et al., 2010), however we only found a weak relationship between IJV CSA and nICP-TCD 
(rrm=0.19, p<0.001) as well as IJV CSA and ONSD (rrm=0.21, p<0.05). Although increases in ICP 
have been attributed to cerebral venous congestion which is thought to result in an increase in IJV 
CSA (Arbeille et al., 2001, 2015a; Davies et al., 1996; Marshall-Goebel et al., 2016, 2018; Stone 
et al., 2010), Lawley et al., (2017) found that despite a significant increase in IJV CSA, ICP 
decreased during parabolic flight, adding complexity into the relationship between IJV CSA, 
cerebral venous congestion, and its effect on ICP, especially in microgravity. It is likely that the 
relationship between cerebral venous congestion and ICP and nICP is much more complicated 
than this study could capture by only looking at associations between IJV CSA, IJV blood flow, 
and nICP-TCD, especially with a small sample size. Overall, further research should be completed 
that determines the relationship between indicators of cerebral venous congestion and their effect 
on ICP and nICP, especially during cephalad fluid shift.  
7.0 LIMITATIONS: 
Due to the COVID-19 pandemic, research labs at the University of Waterloo – Research 
Institute for Aging were shut down indefinitely on March 16, 2020. At this time, we had only 
completed data collection for 11 out of 16 planned participants, with the last five participants 
scheduled to come in for testing the week of March 16, 2020. Due to this, the current study is 
underpowered, which is possibly contributing to the lack of strong effects within the study. In 
addition, of these final five scheduled participants, three were to have a venous catheter inserted 
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in order to measure CVP. Currently, we only have CVP data on five participants, making it difficult 
to make comparisons between CVP and other measures, such as nICP-TCD and JVA as was 
originally planned.  
Currently, in order for CHI to take analyzable images with strong signal quality, strict 
imaging conditions must be met. This includes the use of a pure white calibration target that was 
to be fitted from the collarbone to the mandible and wrapped flat against and around the 
participant’s neck, without any folding up at the edges. Only the area that is covered by the 
calibration target can be compared across conditions. In some cases, the calibration targets did not 
properly fit the participant’s neck, resulting in the target not reaching the collarbone. This impacted 
the area in which the CHI signal could be analyzed, and possibly resulting in weaker signal for 
some participants. CHI also requires the angle of illumination and camera view to be almost 
identical between positions in order to properly analyze the signal. While this was accomplished 
most of the time by visually aligning the camera’s field of view preview, FOP02 and FOP06 had 
slightly different baseline CHI angles compared to the rest of the images, making us less confident 
in the amount of change in CHI signal. In addition, the optimal illumination and camera view angle 
is always 90° (perpendicular) to the neck, an angle which is more difficult to achieve with severe 
HDT. This may have had an impact on signal quality of the CHI.  
CHI also has limitation in the interpretation of results. Firstly, CHI has no ground truth 
value for absorbance. Absorbance, and therefore JVA, is a unitless measurement and will differ 
depending on an individual’s tissue optical properties such as skin tone, adiposity, and vessel 
depth, making it difficult to interpret changes in JVA if other factors cannot be assumed to be 
constant and difficult to compare differences in JVA among individuals. Lastly, while interpreting 
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JVA, it is assumed that all changes in JVA are directly a result of blood volume changes in the IJV 
and not from the surrounding tissue.  
The limitations of nICP-TCD and ONSD are both explicitly discussed in section 6.3 of this 
document.  
The current study utilized measurements at specific five-minute intervals during each HDT 
condition. Due to the specific time constraints and the length of some measurements, occasionally 
a set of measurements would have to be missed. While this only happened for a total of 4 time 
points, it may have limited the analysis looking at how variables changed across time within an 
HDT condition. In order to reduce the impact of this limitation, a mixed model approach was used 
instead of an ANOVA.  
8.0 SIGNIFICANCE AND FUTURE DIRECTIONS:  
Invasive, interventricular catheter is the gold standard method of measuring ICP but carries 
risk for infection and hemorrhage and therefore can not be done during spaceflight. Currently, 
there are very few validated methods of measuring ICP non-invasively, and those methods still all 
require contact with the skin, expensive equipment, operator training and are not always readily 
available in extreme remote environments such as the ISS. In addition, these current nICP methods 
require the astronauts to not only take time to train on the equipment but take valuable time in 
order to complete scanning during spaceflight missions. Being able to have a validated and reliable 
method to indicate ICP during spaceflight is essential as astronauts are returning from long 
durations in space with a condition that results in worse vision and ophthalmic changes (SANS). 
In order to better understand SANS, a non-invasive, validated, reliable method for indicating ICP 
is needed. This study had the potential to show how venous information derived from non-contact, 
zero-effort CHI imaging could be a beneficial method of indicating ICP in hostile environments 
such as microgravity 
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While JVA, measured by CHI, has proven to be a moderate to strong cardiovascular 
biomarker for HR, BP, and the jugular venous pulse (Amelard et al., 2016, 2017, 2015), JVA had 
a weak association with nICP-TCD. Although both CHI and nICP-TCD have limitations that may 
contribute to the weak association, evidence from the current study suggests that CHI does not 
provide the same information as an nICP surrogate. The ability to test CHI against invasive ICP 
monitoring would provide stronger clarity about the associations between CHI and ICP and more 
strongly indicate if CHI is a suitable nICP surrogate.  
The current study also provided evidence that JVA had moderate to strong associations 
with IJV CSA and CVP during a severe cephalad fluid shift induced by 12° HDT and 30° HDT. 
This could reflect the plateauing of the venous pressure-volume curve or could indicate that CHI’s 
ability to track venous physiological changes is limited when large cephalad fluid shifts are 
occurring. Further testing of CHI’s ability to track changes in IJV CSA, CVP and nICP during 
large cephalad fluid shifts is warranted, in order to better understand the limits of the CHI itself. 
This will be partially tested during a parabolic flight occurring in 2021. The parabolic flight 
experiment will provide us information on CHI’s accuracy during periods of both hyper and 
microgravity.  
As development of the CHI continues, in order to provide more clinically valuable 
information, effort should be made to convert JVA, normally a unitless measurement (a.u.), to a 
clinically recognizable value, such as mmHg. Currently, JVA on its own has little significance as 
a single value, and instead has value when compared to other values taken overtime within the 
same individual. While this is valuable for tracking intra-individual changes over time, the value 
on its own does not indicate if physiological variables, such as CVP or nICP are elevated to begin 
with, or how much they may be changing over time. This limits the ability of the CHI to be used 
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in a clinical setting, especially in immediate screening situations such as in the emergency 
department, although is still valuable in situations such as in heart failure where CVP is assessed 
by tilting patients.  
Finally, the impact of cerebral venous congestion on nICP in both severe HDT and 
microgravity warrants further research. Evidence from our study suggests that IJV blood flow 
quantity and IJV CSA during severe HDT do not have strong associations with nICP-TCD, 
suggesting that cerebral venous congestion may be more impacted by the presence of non-linear 
and stagnated blood flow rather than the quantity of flow itself. Evidence suggests that separate 
mechanisms may impact IJV blood flow patterns in HDT and microgravity (Marshall-goebel et 
al., 2019), which may in turn impact differences in ICP that could lead to the development of 
SANS. These mechanisms should continue to be explored using ultrasound designed to track blood 
flow patterns, such as the high frame rate ultrasound system (HiFRUS)(Yiu, 2019), during both 
severe HDT and periods of microgravity, such as on a parabolic flight.  
9.0 CONCLUSION: 
This study aimed to determine the ability of the novel, non-contact CHI system to provide 
information on changes in IJV CSA, CVP and nICP during a severe cephalad fluid shift induced 
by 12° HDT and 30° HDT. Overall, JVA measured by CHI was found to have a moderate 
association with both IJV CSA and CVP during a severe cephalad fluid shift but only a weak 
association with measures of nICP. That is, JVA measured by CHI was able to monitor and track 
changes in cardiovascular biomarkers that indicate increased jugular vein volume and pressure 
during a cephalad fluid shift. These results are similar to recent research from our lab that provided 
evidence of a linear increase in JVA with the increase in CVP during a Valsalva maneuver 
(Amelard et al., submitted).  The weak relationship between JVA and nICP estimated by TCD and 
ONSD might reflect uncertainties in these non-invasive methodologies to reliably represent true 
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ICP. Further research should determine if JVA as determined by CHI diminishes at a certain blood 
volume or pressure therefore creating an upper limit of reliability. If an upper limit exists, it should 
be determined if this would impact measurements taken during the cephalad fluid shift that occurs 
in microgravity. Due to the limitations that exist with nICP, CHI-derived-JVA should be compared 
to invasive measures of ICP in order to make a more valid conclusion about CHI’s ability to act 
as an nICP surrogate.  
 This study also sought to determine the effect of severe cephalad fluid shifts on cerebral 
venous outflow via IJV blood flow and IJV CSA, and how these changes were associated with 
measures of nICP. A severe cephalad fluid shift was found to induce a significant increase in IJV 
CSA and nICP-TCD but not significantly change IJV blood flow or ONSD. HDT had a significant 
main effect on IJV CSA, nICP-TCD, and ONSD but not IJV blood flow, however no main effect 
of time was found on any variable. This suggests that when identifying short-term effects of severe 
cephalad fluid shifts via HDT, short condition times of 5-minutes would be sufficient. Overall, no 
associations were found between measures of cerebral venous outflow and nICP measures. 
Contrary to Hypothesis #2, IJV blood flow was not decreased with severe HDT and did not have 
an association with nICP, suggesting that absolute IJV blood flow may not be a contributor to 
changes in nICP during a cephalad fluid shift. Further research should focus on identifying markers 
of complex IJV flow and determine how complex flow impacts cerebral venous outflow and 
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